<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS One</journal-id><journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title-group><journal-title>PLoS ONE</journal-title></journal-title-group><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24475060</article-id><article-id pub-id-type="pmc">3901664</article-id><article-id pub-id-type="publisher-id">PONE-D-13-31817</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0085928</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline-v2"><subject>Medicine</subject><subj-group><subject>Cardiovascular</subject><subj-group><subject>Coronary Artery Disease</subject><subject>Heart Failure</subject></subj-group></subj-group><subj-group><subject>Clinical Research Design</subject><subj-group><subject>Clinical Trials</subject></subj-group></subj-group><subj-group><subject>Mental Health</subject><subj-group><subject>Psychiatry</subject><subj-group><subject>Anxiety Disorders</subject><subject>Mood Disorders</subject><subject>Personality Disorders</subject><subject>Substance Abuse</subject></subj-group></subj-group><subj-group><subject>Psychology</subject><subj-group><subject>Clinical Psychology</subject></subj-group></subj-group></subj-group></subj-group></article-categories><title-group><article-title>The Real World Mental Health Needs of Heart Failure Patients Are Not Reflected by the Depression Randomized Controlled Trial Evidence</article-title><alt-title alt-title-type="running-head">Mental Health Needs in Heart Failure Patients</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Tully</surname><given-names>Phillip J.</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref><xref ref-type="corresp" rid="cor1">
<sup>*</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Wittert</surname><given-names>Gary</given-names></name><xref ref-type="aff" rid="aff3">
<sup>3</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Selkow</surname><given-names>Terina</given-names></name><xref ref-type="aff" rid="aff4">
<sup>4</sup>
</xref></contrib><contrib contrib-type="author"><name><surname>Baumeister</surname><given-names>Harald</given-names></name><xref ref-type="aff" rid="aff1">
<sup>1</sup>
</xref><xref ref-type="aff" rid="aff2">
<sup>2</sup>
</xref></contrib></contrib-group><aff id="aff1">
<label>1</label>
<addr-line>Department of Rehabilitation Psychology and Psychotherapy, Institute of Psychology, University of Freiburg, Freiburg, Germany</addr-line>
</aff><aff id="aff2">
<label>2</label>
<addr-line>Medical Psychology and Medical Sociology, Medical Faculty, University of Freiburg, Freiburg, Germany</addr-line>
</aff><aff id="aff3">
<label>3</label>
<addr-line>Freemasons Foundation Centre for Men&#x02019;s Health, Discipline of Medicine, School of Medicine, The University of Adelaide, Adelaide, Australia</addr-line>
</aff><aff id="aff4">
<label>4</label>
<addr-line>Heart Failure Support Service, The Queen Elizabeth Hospital, Woodville, Australia</addr-line>
</aff><contrib-group><contrib contrib-type="editor"><name><surname>Quinn</surname><given-names>Terence J.</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">
<addr-line>University of Glasgow, United Kingdom</addr-line>
</aff><author-notes><corresp id="cor1">* E-mail: <email>phillip.tully@adelaide.edu.au</email></corresp><fn fn-type="COI-statement"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="con"><p>Conceived and designed the experiments: PJT GAW TS HB. Performed the experiments: PJT TS. Analyzed the data: PJT GAW TS HB. Wrote the paper: PJT GAW TS HB.</p></fn></author-notes><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>24</day><month>1</month><year>2014</year></pub-date><volume>9</volume><issue>1</issue><elocation-id>e85928</elocation-id><history><date date-type="received"><day>6</day><month>8</month><year>2013</year></date><date date-type="accepted"><day>4</day><month>12</month><year>2013</year></date></history><permissions><copyright-statement>&#x000a9; 2014 Tully et al</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Tully et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited.</license-p></license></permissions><abstract><sec><title>Introduction</title><p>International depression screening guidelines in heart failure (HF) are partly based on depression treatment efficacy from randomized controlled trials (RCTs). Our aim was to test the external validity of depression RCT criteria in a sample of real-world HF patients.</p></sec><sec><title>Methods</title><p>HF patients admitted to 3 hospitals in South Australia were referred to a HF psychologist if not already receiving current psychiatric management by psychologist or psychiatrist elsewhere. Screening and referral protocol consisted of the following; (a). Patient Health Questionnaire &#x02265;10; (b). Generalized Anxiety Disorder Questionnaire &#x02265;7); (c). positive response to 1 item panic attack screener; (d). evidence of suicidality. Patients were evaluated against the most common RCT exclusion criteria personality disorder, high suicide risk, cognitive impairment, psychosis, alcohol or substance abuse or dependency, bi-polar depression.</p></sec><sec><title>Results</title><p>Total 81 HF patients were referred from 404 HF admissions, and 73 were assessed (age 60.6&#x000b1;13.4, 47.9% female). Nearly half (47%) met at least 1 RCT exclusion criterion, most commonly personality disorder (28.5%), alcohol/substance abuse (17.8%) and high suicide risk (11.0%). RCT ineligibility criteria was more frequent among patients with major depression (76.5% vs. 46.2%, p&#x0003c;.01) and dysthymia (26.5% vs. 7.7%, p&#x0200a;=&#x0200a;.03) but not significantly associated with anxiety disorders. RCT ineligible patients reported greater severity of depression (M&#x0200a;=&#x0200a;16.6&#x000b1;5.0 vs. M&#x0200a;=&#x0200a;12.9&#x000b1;7.2, p&#x0200a;=&#x0200a;.02) and were higher consumers of HF psychotherapy services (M&#x0200a;=&#x0200a;11.5&#x000b1;4.7 vs. M&#x0200a;=&#x0200a;8.5&#x000b1;4.8, p&#x0200a;=&#x0200a;.01).</p></sec><sec><title>Conclusion</title><p>In this real-world sample comparable in size to recent RCT intervention arms, patients with depression disorders presented with complex psychiatric needs including comorbid personality disorders, alcohol/substance use and suicide risk. These findings suggest external validity of depression screening and RCTs could serve as a basis for level A guideline recommendations in cardiovascular diseases.</p></sec></abstract><funding-group><funding-statement>Dr Phillip John Tully is supported by the National Health and Medical Research Council of Australia (Neil Hamilton Fairley - Clinical Overseas Fellowship # 1053578). The article processing charge which funded by the Open Access publication fund of the Albert Ludwigs University of Freiburg. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement></funding-group><counts><page-count count="8"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Depression has gained widespread research attention with respect to prognosis of heart diseases including heart failure (HF) <xref rid="pone.0085928-Ferrari1" ref-type="bibr">[1]</xref>. A meta-analysis by Rutledge et al. <xref rid="pone.0085928-Rutledge1" ref-type="bibr">[2]</xref> suggested that the prevalence of clinical depression was 22% in HF, thus substantially higher than community prevalence estimates for populations free from heart failure <xref rid="pone.0085928-American1" ref-type="bibr">[3]</xref>. It has been consistently shown that depression doubles the risk of major cardiac events and death in patients with documented HF <xref rid="pone.0085928-Rutledge1" ref-type="bibr">[2]</xref>, <xref rid="pone.0085928-Jiang1" ref-type="bibr">[4]</xref>, <xref rid="pone.0085928-OConnor1" ref-type="bibr">[5]</xref>, increases healthcare costs <xref rid="pone.0085928-Smith1" ref-type="bibr">[6]</xref>, significantly impairs quality of life <xref rid="pone.0085928-Baumeister1" ref-type="bibr">[7]</xref>&#x02013;<xref rid="pone.0085928-Samartzis1" ref-type="bibr">[9]</xref>, impairs self-care ability <xref rid="pone.0085928-Holzapfel1" ref-type="bibr">[10]</xref> and impacts upon participation in HF disease-management strategies <xref rid="pone.0085928-Jaarsma2" ref-type="bibr">[11]</xref>. Consequently, depression identification and management is emphasized in international cardiology guidelines <xref rid="pone.0085928-Lichtman1" ref-type="bibr">[12]</xref>&#x02013;<xref rid="pone.0085928-Albus1" ref-type="bibr">[15]</xref>, HF treatment guidelines <xref rid="pone.0085928-McMurray1" ref-type="bibr">[16]</xref> and HF self-management recommendations <xref rid="pone.0085928-Lainscak1" ref-type="bibr">[17]</xref>.</p><p>Though a number of studies have applied routine depression screening protocols to improve recognition of depression <xref rid="pone.0085928-Luttik1" ref-type="bibr">[18]</xref>&#x02013;<xref rid="pone.0085928-Jani1" ref-type="bibr">[27]</xref> a paucity of information exists regarding the ensuing mental health management strategies initiated within cardiology settings from a positive depression-screen <xref rid="pone.0085928-Hasnain1" ref-type="bibr">[22]</xref>, <xref rid="pone.0085928-Thombs1" ref-type="bibr">[28]</xref>&#x02013;<xref rid="pone.0085928-Annunziato1" ref-type="bibr">[31]</xref>. Thombs and colleagues systematic reviews confirm that a number of issues regarding routine screening remain unclear <xref rid="pone.0085928-Thombs1" ref-type="bibr">[28]</xref>, <xref rid="pone.0085928-Thombs2" ref-type="bibr">[29]</xref>. As the utility for depression screening alone in reducing depression and cardiovascular morbidity has not been established <xref rid="pone.0085928-Hasnain1" ref-type="bibr">[22]</xref>, randomised, controlled trials (RCTs) provide Level A empirical evidence to guide clinical practice for depression management in HF <xref rid="pone.0085928-Rutledge1" ref-type="bibr">[2]</xref>, <xref rid="pone.0085928-Woltz1" ref-type="bibr">[32]</xref>. For example, the Safety and Efficacy of Sertraline for Depression in Patients with Chronic Heart Failure trial was designed to facilitate easy translation into clinical practice <xref rid="pone.0085928-Jiang2" ref-type="bibr">[33]</xref>. Unfortunately, however, the extant depression RCT evidence in HF <xref rid="pone.0085928-Woltz1" ref-type="bibr">[32]</xref>&#x02013;<xref rid="pone.0085928-Gary1" ref-type="bibr">[36]</xref> has not been subjected to tests of external and ecological validity and therefore, the implications for clinical practice are not known <xref rid="pone.0085928-Rothwell1" ref-type="bibr">[37]</xref>. Moreover, if external validity of depression RCTs is not established then unrealistic expectations regarding depression treatment response may be fostered among clinicians and patients alike <xref rid="pone.0085928-vanderLem1" ref-type="bibr">[38]</xref>. Complicating these matters further, the American Heart Association guidelines recommend comprehensive assessment of other mental disorders such as anxiety <xref rid="pone.0085928-Lichtman1" ref-type="bibr">[12]</xref> which are present in 30% of RCT patients with positive depression screen <xref rid="pone.0085928-Rollman1" ref-type="bibr">[39]</xref>. Yet Hasnain and colleagues <xref rid="pone.0085928-Hasnain1" ref-type="bibr">[22]</xref> also emphasize the lack of guidance for individualized depression treatment plans when such comorbidity is present. Consequently, underestimation of the complexity of real-world mental health treatment needs may hamper concerted efforts to implement depression screening guidelines <xref rid="pone.0085928-Lichtman1" ref-type="bibr">[12]</xref>, <xref rid="pone.0085928-ChronicHeartFailureGuidelinesExpertWriting1" ref-type="bibr">[13]</xref>, <xref rid="pone.0085928-McMurray1" ref-type="bibr">[16]</xref>, <xref rid="pone.0085928-Lainscak1" ref-type="bibr">[17]</xref> and integrate depression management into HF clinical practice <xref rid="pone.0085928-Smolderen1" ref-type="bibr">[19]</xref>, <xref rid="pone.0085928-Ruscio1" ref-type="bibr">[40]</xref>, <xref rid="pone.0085928-Collins1" ref-type="bibr">[41]</xref>.</p><p>The topical nature of routine depression and anxiety screening <xref rid="pone.0085928-Thombs1" ref-type="bibr">[28]</xref>, <xref rid="pone.0085928-Thombs2" ref-type="bibr">[29]</xref> suggests it is timely to examine the practical implementation of integrated mental health care within real-world HF settings <xref rid="pone.0085928-HerrmannLingen1" ref-type="bibr">[30]</xref> subsequent to guideline based routine depression-screening initiatives. This study reports on referrals to a HF-specific psychologist generated from routine depression and anxiety screening in three public hospitals in Adelaide, South Australia. The following research questions will be answered:</p><list list-type="order"><list-item><p>To what extent are real-word HF-patients with depression covered by the inclusion and exclusion criteria of RCTs on depression in HF patients?</p></list-item><list-item><p>Do RCT ineligible patients differ from RCT eligible patients with respect to demographic and clinical characteristics?</p></list-item><list-item><p>What are the prevalence rates of various depression and anxiety disorders among HF patients referred for integrated mental health management after routine depression and anxiety screening?</p></list-item></list></sec><sec sec-type="methods" id="s2"><title>Methods</title><sec id="s2a"><title>Patient Selection</title><p>This study received ethics approval and all participants provided written and informed consent prior to assessment (Human Research Ethics Committee of The Queen Elizabeth Hospital, Lyell McEwin Hospital and Royal Adelaide Hospital #HREC/12/TQEHLMH/188). Between April 2011 and June 2012 patients with verified HF admission were managed by specialist HF nurses in a HF self-management program (HFSMP) <xref rid="pone.0085928-Lainscak1" ref-type="bibr">[17]</xref> at three South Australian hospitals (Queen Elizabeth Hospital, Royal Adelaide Hospital, Lyell McEwin Hospital). During this period specialist HF nurses routinely screened patients with validated questionnaires and referred patients to the HFSMP psychologist when either of the following criteria were met; (a). depression symptoms were in the clinically significant range (Patient Health Questionnaire (PHQ-9) &#x02265;10); (b). anxiety symptoms were in the clinically significant range (Generalized Anxiety Disorder (GAD-7) &#x02265;7); (c). patients had evidence of panic attack (N.B. questionnaires described further below). (d). there was evidence of suicidality (PHQ or identified by nurse). Median time between referral and assessment was 20 days. A flow chart of participants through the study is shown in <xref ref-type="fig" rid="pone-0085928-g001">Figure 1</xref>.</p><fig id="pone-0085928-g001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085928.g001</object-id><label>Figure 1</label><caption><title>Flow chart of patients through the study.</title></caption><graphic xlink:href="pone.0085928.g001"/></fig></sec><sec id="s2b"><title>HFSMP and Consent Process</title><p>Referred patients were contacted by telephone to schedule the initial mental health assessment and all facets of HFSMP care was provided at no cost. The HFSMP was community based, delivered flexibly at home visit, hospital site, or prior to weekly HFSMP exercise classes at Hampstead Rehabilitation Hospital. Ineligibility criteria for psychologist referral was not having cardiologist verified HF or currently receiving psychology and/or psychiatrist support elsewhere.</p><p>Patients who consented to standard HFSMP psychology assessment were free to refuse treatment at any time in accordance with ethical guidelines and government primary health care protocols. Patients not desiring the HFSMP psychology assessment (n&#x0200a;=&#x0200a;5) were provided with alternative counselling arrangements including psychiatrist referral, local psychologist support and tele-counselling. Refusal did not impinge on standard cardiology care. HFSMP psychology was withdrawn in cases when patients transitioned to a palliative care team and the associated mental health supports. Patients requiring acute psychiatric care were managed by the treating psychologist in collaboration with the 24 hour South Australian Mental Health Emergency Triage Service for Community and Older Persons (Acute Crisis Intervention Service).</p></sec><sec id="s2c"><title>Psychological Assessment</title><p>Referred patients repeated the depression and anxiety questionnaire at the psychologist intake assessment and again before each subsequent psychologist appointment to verify symptom response to treatment. The PHQ-9 <xref rid="pone.0085928-Spitzer1" ref-type="bibr">[42]</xref> is a 9 item depression questionnaire covering major depression disorder criteria demarcated by DSM-IV <xref rid="pone.0085928-American1" ref-type="bibr">[3]</xref>. Respondents endorse items based on the previous two-weeks on a scale of 0 &#x0201c;not at all&#x0201d; to 3 &#x0201c;nearly every day.&#x0201d; PHQ scores &#x02265;10 warrant further evaluation according to the American Heart Association guidelines <xref rid="pone.0085928-Lichtman1" ref-type="bibr">[12]</xref> and have favorable sensitivity and specificity for detection of depression disorder in heart disease populations <xref rid="pone.0085928-McManus1" ref-type="bibr">[43]</xref>.</p><p>Patients also completed an 8 item questionnaire regarding anxiety (Generalized Anxiety Disorder-7, 7 items (GAD-7); and a one-item panic screener &#x0201c;<italic>In the last 4 weeks, have you had an anxiety attack &#x02013; suddenly feeling fear or panic</italic>?&#x0201d;) <xref rid="pone.0085928-Kroenke1" ref-type="bibr">[44]</xref>&#x02013;<xref rid="pone.0085928-Kroenke2" ref-type="bibr">[46]</xref>. The GAD-7 is a 7 item anxiety questionnaire covering Generalized Anxiety Disorder criteria demarcated by DSM-IV <xref rid="pone.0085928-American1" ref-type="bibr">[3]</xref> and GAD-7 scores &#x02265;7 warrant further evaluation <xref rid="pone.0085928-Kroenke2" ref-type="bibr">[46]</xref>. The single-item panic disorder screener also showed favorable sensitivity and specificity in detection of panic disorder amongst medical and psychosomatic medicine populations <xref rid="pone.0085928-Lwe1" ref-type="bibr">[47]</xref>. The anxiety measures were selected in addition to depression screening as the American Heart Association <xref rid="pone.0085928-Lichtman1" ref-type="bibr">[12]</xref> guidelines advocate comprehensive assessment of anxiety disorders. Also, anxiety disorders are highly prevalent in heart diseases and predict higher rates of cardiovascular morbidity and mortality in patients with heart disease <xref rid="pone.0085928-Pedersen1" ref-type="bibr">[48]</xref>&#x02013;<xref rid="pone.0085928-Tully2" ref-type="bibr">[54]</xref>.</p><p>Patients were assessed with the Structured Clinical Interview for DSM-IV Axis-I and AXIS-II disorders <xref rid="pone.0085928-First1" ref-type="bibr">[55]</xref>, <xref rid="pone.0085928-First2" ref-type="bibr">[56]</xref>. The SCID is a widely validated interview with favourable psychometric properties. Psychologist diagnoses were verified by two senior clinical psychologists once per month.</p></sec><sec id="s2d"><title>Comparison with RCT Exclusion Criteria</title><p>Comparison of the present community treatment sample against RCT exclusion criteria focussed on depression interventions as there are no known anxiety disorder interventions in HF patients. Ineligibility for RCT was determined from the recent systematic review of depression interventions in HF reported by Woltz and colleagues <xref rid="pone.0085928-Woltz1" ref-type="bibr">[32]</xref>. Woltz et al. <xref rid="pone.0085928-Woltz1" ref-type="bibr">[32]</xref> evaluated 23 experimental and quasiexperimental HF trails (Total N&#x0200a;=&#x0200a;3,564 patients) reporting depression symptom change from a range of interventions. Here we focussed solely on the six RCTs that evaluated either antidepressant or psychotherapy (i.e. cognitive-behavioural therapy, relaxation, mindfulness stress reduction) <xref rid="pone.0085928-Jiang2" ref-type="bibr">[33]</xref>, <xref rid="pone.0085928-Gary1" ref-type="bibr">[36]</xref>, <xref rid="pone.0085928-Gottlieb1" ref-type="bibr">[57]</xref>&#x02013;<xref rid="pone.0085928-Yu1" ref-type="bibr">[61]</xref>. Ineligibility of our real world patients was determined against the six most common RCT exclusion criteria extracted from the included trials in Woltz et al <xref rid="pone.0085928-Annunziato1" ref-type="bibr">[31]</xref>:</p><list list-type="order"><list-item><p>personality disorder <xref rid="pone.0085928-Jiang2" ref-type="bibr">[33]</xref>, <xref rid="pone.0085928-Gary1" ref-type="bibr">[36]</xref>, <xref rid="pone.0085928-Lekakis1" ref-type="bibr">[58]</xref>, <xref rid="pone.0085928-Yu1" ref-type="bibr">[61]</xref>: SCID diagnosis of a personality disorder</p></list-item><list-item><p>suicide risk <xref rid="pone.0085928-Jiang2" ref-type="bibr">[33]</xref>, <xref rid="pone.0085928-Gary1" ref-type="bibr">[36]</xref>, <xref rid="pone.0085928-Gottlieb1" ref-type="bibr">[57]</xref>, <xref rid="pone.0085928-Fraguas1" ref-type="bibr">[59]</xref>; score of PHQ item 9&#x02265;2, verified at structured interview</p></list-item><list-item><p>cognitive impairment <xref rid="pone.0085928-Jiang2" ref-type="bibr">[33]</xref>, <xref rid="pone.0085928-Gary1" ref-type="bibr">[36]</xref>, <xref rid="pone.0085928-Gottlieb1" ref-type="bibr">[57]</xref>, <xref rid="pone.0085928-Yu1" ref-type="bibr">[61]</xref>: Mini Mental State Examination &#x02264;23, verified dementia or developmental disorder</p></list-item><list-item><p>current or past psychosis <xref rid="pone.0085928-Jiang2" ref-type="bibr">[33]</xref>, <xref rid="pone.0085928-Gary1" ref-type="bibr">[36]</xref>, <xref rid="pone.0085928-Gottlieb1" ref-type="bibr">[57]</xref>, <xref rid="pone.0085928-Fraguas1" ref-type="bibr">[59]</xref>, <xref rid="pone.0085928-Yu1" ref-type="bibr">[61]</xref>: SCID diagnosis of a psychotic episode/disorder</p></list-item><list-item><p>active alcohol/substance abuse or dependency <xref rid="pone.0085928-Jiang2" ref-type="bibr">[33]</xref>, <xref rid="pone.0085928-Gottlieb1" ref-type="bibr">[57]</xref>, <xref rid="pone.0085928-Fraguas1" ref-type="bibr">[59]</xref>&#x02013;<xref rid="pone.0085928-Yu1" ref-type="bibr">[61]</xref>: SCID diagnosis of alcohol/substance abuse or dependency</p></list-item><list-item><p>current or past bi-polar <xref rid="pone.0085928-Jiang2" ref-type="bibr">[33]</xref>, <xref rid="pone.0085928-Fraguas1" ref-type="bibr">[59]</xref>, <xref rid="pone.0085928-Yu1" ref-type="bibr">[61]</xref>: SCID diagnosis of bi-polar disorder</p></list-item></list></sec><sec id="s2e"><title>Statistical Analyses</title><p>Data analysis was performed with SPSS&#x000ae; 19.0 (SPSS Inc., Chicago, IL). Descriptive comparisons between RCT eligible and ineligible groups employed the independent samples t-test, and the chi-square statistic with Fisher&#x02019;s exact test as appropriate. All statistical tests were two-tailed, an alpha value p&#x0003c;.05 was considered statistically significant. This exploratory study pertains to RCT criteria validation and we have therefore not adjusted for multiple comparisons <xref rid="pone.0085928-Rothman1" ref-type="bibr">[62]</xref>.</p></sec></sec><sec id="s3"><title>Results</title><p>During the study period 81 patients were referred to HF mental health care, 8 were not included (did not want support (n&#x0200a;=&#x0200a;5), HF death prior to mental health assessment (n&#x0200a;=&#x0200a;2), receiving psychology treatment elsewhere (n&#x0200a;=&#x0200a;1). This left a sample of 73 patients whom underwent mental health assessment and psychotherapy as appropriate (Flow Chart shown in <xref ref-type="fig" rid="pone-0085928-g001">Figure 1</xref>.).</p><sec id="s3a"><title>Prevalence of RCT Eligibility by Depression Criteria</title><p>Nearly half (46.6%) of assessed patients would be excluded from RCTs according to the six standard exclusion criteria (<xref ref-type="table" rid="pone-0085928-t001">Table 1</xref>). The most common RCT exclusion criterions were personality disorder (28.8%), alcohol/substance abuse or dependency (17.8%) and suicide risk (11.0%). Analysis comparing the proportion of each RCT eligibility criteria between patients with depression disorder (major depression or dysthymia &#x000b1; any anxiety) with those without depression disorder showed that patients with a mood disorder were more likely to meet at least 1 RCT exclusion criteria (60.4% vs. 29%, p&#x0003c;.001), particularly personality disorder (41.7% vs. 4.0%, p&#x0003c;.001) and alcohol/substance abuse or dependency (25.0% vs. 4.0%, p&#x0200a;=&#x0200a;.03). The proportion of RCT exclusion criteria by depression diagnosis is depicted in <xref ref-type="fig" rid="pone-0085928-g002">Figure 2</xref>.</p><fig id="pone-0085928-g002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085928.g002</object-id><label>Figure 2</label><caption><title>Proportion of standard RCT exclusion criteria met by HF patients according to depression status (yes vs. no).</title></caption><graphic xlink:href="pone.0085928.g002"/></fig><table-wrap id="pone-0085928-t001" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085928.t001</object-id><label>Table 1</label><caption><title>Psychiatric RCT ineligibility in heart failure patients referred for psychiatric care according to depression status.</title></caption><alternatives><graphic id="pone-0085928-t001-1" xlink:href="pone.0085928.t001"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">
<italic>Psychiatric RCT exclusions</italic>
</td><td align="left" rowspan="1" colspan="1">Total N(%)N&#x0200a;=&#x0200a;73</td><td align="left" rowspan="1" colspan="1">No Depression(N&#x0200a;=&#x0200a;25)</td><td align="left" rowspan="1" colspan="1">Depression(N&#x0200a;=&#x0200a;48)</td><td align="left" rowspan="1" colspan="1">P</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Personality disorder</td><td align="left" rowspan="1" colspan="1">21 (28.8)</td><td align="left" rowspan="1" colspan="1">1 (4.0)</td><td align="left" rowspan="1" colspan="1">20 (41.7)</td><td align="left" rowspan="1" colspan="1">.001<xref ref-type="table-fn" rid="nt102">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">High suicide risk</td><td align="left" rowspan="1" colspan="1">8 (11.0)</td><td align="left" rowspan="1" colspan="1">3 (12.0)</td><td align="left" rowspan="1" colspan="1">5 (10.4)</td><td align="left" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Cognitive impairment</td><td align="left" rowspan="1" colspan="1">3 (4.1)</td><td align="left" rowspan="1" colspan="1">2 (8.0)</td><td align="left" rowspan="1" colspan="1">1 (2.1)</td><td align="left" rowspan="1" colspan="1">.27</td></tr><tr><td align="left" rowspan="1" colspan="1">Current or past psychosis</td><td align="left" rowspan="1" colspan="1">2 (2.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (4.2)</td><td align="left" rowspan="1" colspan="1">.54</td></tr><tr><td align="left" rowspan="1" colspan="1">Active alcohol/substance abuse or dependency</td><td align="left" rowspan="1" colspan="1">13 (17.8)</td><td align="left" rowspan="1" colspan="1">1 (4.0)</td><td align="left" rowspan="1" colspan="1">12 (25.0)</td><td align="left" rowspan="1" colspan="1">.03<xref ref-type="table-fn" rid="nt102">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Current or past bi-polar</td><td align="left" rowspan="1" colspan="1">2 (2.7)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">2 (4.2)</td><td align="left" rowspan="1" colspan="1">.54</td></tr><tr><td align="left" rowspan="1" colspan="1">Met any RCT exclusion criteria</td><td align="left" rowspan="1" colspan="1">34 (46.6)</td><td align="left" rowspan="1" colspan="1">5 (20.0)</td><td align="left" rowspan="1" colspan="1">29 (60.4)</td><td align="left" rowspan="1" colspan="1">.001<xref ref-type="table-fn" rid="nt102">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Number of RCT exclusion criteria met</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">&#x0003c;.01<xref ref-type="table-fn" rid="nt102">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">1</td><td align="left" rowspan="1" colspan="1">23 (31.5)</td><td align="left" rowspan="1" colspan="1">3 (12.0)</td><td align="left" rowspan="1" colspan="1">20 (41.7)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">2</td><td align="left" rowspan="1" colspan="1">7 (9.6)</td><td align="left" rowspan="1" colspan="1">2 (8.0)</td><td align="left" rowspan="1" colspan="1">5 (10.4)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">3</td><td align="left" rowspan="1" colspan="1">4 (5.5)</td><td align="left" rowspan="1" colspan="1">0</td><td align="left" rowspan="1" colspan="1">4 (8.3)</td><td align="left" rowspan="1" colspan="1"/></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt101"><label/><p>
<italic>RCT, randomized controlled trial.</italic>
</p></fn><fn id="nt102"><label>*</label><p>
<italic>p&#x0003c;.05.</italic>
</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3b"><title>Demographic Descriptives According to RCT Eligibility</title><p>Comparison of the RCT eligible and ineligible patients with respect to demographics and comorbidities is shown in <xref ref-type="table" rid="pone-0085928-t002">Table 2</xref> (age M&#x0200a;=&#x0200a;60.6&#x000b1;13.4, 47.9% female, 8.2% Indigenous Australian). RCT ineligible patients were more likely to have chronic pain documented in medical records (29.4% vs. 10.3%, p&#x0200a;=&#x0200a;.04). Ineligible patients were also less likely to have had a prior myocardial infarction (32.4% vs. 59.0%, p&#x0200a;=&#x0200a;.03), and there were no other significant differences.</p><table-wrap id="pone-0085928-t002" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085928.t002</object-id><label>Table 2</label><caption><title>Comparison of RCT eligible and ineligible patients on demographics and medical comorbidity.</title></caption><alternatives><graphic id="pone-0085928-t002-2" xlink:href="pone.0085928.t002"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1">Total N(%)N&#x0200a;=&#x0200a;73</td><td align="left" rowspan="1" colspan="1">RCT EligibleN&#x0200a;=&#x0200a;39</td><td align="left" rowspan="1" colspan="1">RCT IneligibleN&#x0200a;=&#x0200a;34</td><td align="left" rowspan="1" colspan="1">P</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">
<italic><underline>Demographic and comorbidity factors</underline></italic>
</td><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Female</td><td align="left" rowspan="1" colspan="1">35 (47.9)</td><td align="left" rowspan="1" colspan="1">18 (46.2)</td><td align="left" rowspan="1" colspan="1">17 (50.0)</td><td align="left" rowspan="1" colspan="1">.74</td></tr><tr><td align="left" rowspan="1" colspan="1">Age, M(SD)</td><td align="left" rowspan="1" colspan="1">60.6 (13.4)</td><td align="left" rowspan="1" colspan="1">60.7 (13.9)</td><td align="left" rowspan="1" colspan="1">60.6 (13.1)</td><td align="left" rowspan="1" colspan="1">.98</td></tr><tr><td align="left" rowspan="1" colspan="1">Lives on own</td><td align="left" rowspan="1" colspan="1">19 (26.0)</td><td align="left" rowspan="1" colspan="1">8 (20.5)</td><td align="left" rowspan="1" colspan="1">11 (32.4)</td><td align="left" rowspan="1" colspan="1">.25</td></tr><tr><td align="left" rowspan="1" colspan="1">Disability Pension</td><td align="left" rowspan="1" colspan="1">22 (30.1)</td><td align="left" rowspan="1" colspan="1">11 (28.2)</td><td align="left" rowspan="1" colspan="1">11 (32.4)</td><td align="left" rowspan="1" colspan="1">.70</td></tr><tr><td align="left" rowspan="1" colspan="1">Indigenous Australian</td><td align="left" rowspan="1" colspan="1">6 (8.2)</td><td align="left" rowspan="1" colspan="1">4 (10.3)</td><td align="left" rowspan="1" colspan="1">2 (5.9)</td><td align="left" rowspan="1" colspan="1">.68</td></tr><tr><td align="left" rowspan="1" colspan="1">Current divorce/bereavement</td><td align="left" rowspan="1" colspan="1">8 (11.0)</td><td align="left" rowspan="1" colspan="1">3 (7.7)</td><td align="left" rowspan="1" colspan="1">5 (14.7)</td><td align="left" rowspan="1" colspan="1">.46</td></tr><tr><td align="left" rowspan="1" colspan="1">NYHA Class II</td><td align="left" rowspan="1" colspan="1">26 (35.6)</td><td align="left" rowspan="1" colspan="1">17 (43.6)</td><td align="left" rowspan="1" colspan="1">9 (26.5)</td><td align="left" rowspan="1" colspan="1">.35</td></tr><tr><td align="left" rowspan="1" colspan="1">III</td><td align="left" rowspan="1" colspan="1">39 (53.4)</td><td align="left" rowspan="1" colspan="1">18 (46.2)</td><td align="left" rowspan="1" colspan="1">39 (53.4)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">IV</td><td align="left" rowspan="1" colspan="1">8 (11.0)</td><td align="left" rowspan="1" colspan="1">4 (10.3)</td><td align="left" rowspan="1" colspan="1">8 (11.0)</td><td align="left" rowspan="1" colspan="1"/></tr><tr><td align="left" rowspan="1" colspan="1">Left ventricular ejection fraction</td><td align="left" rowspan="1" colspan="1">33.9 (12.1)</td><td align="left" rowspan="1" colspan="1">34.2 (11.6)</td><td align="left" rowspan="1" colspan="1">33.5 (12.9)</td><td align="left" rowspan="1" colspan="1">.82</td></tr><tr><td align="left" rowspan="1" colspan="1">Prior myocardial infarction</td><td align="left" rowspan="1" colspan="1">34 (46.6)</td><td align="left" rowspan="1" colspan="1">23 (59.0)</td><td align="left" rowspan="1" colspan="1">11 (32.4)</td><td align="left" rowspan="1" colspan="1">.03<xref ref-type="table-fn" rid="nt104">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Atrial fibrillation</td><td align="left" rowspan="1" colspan="1">25 (34.2)</td><td align="left" rowspan="1" colspan="1">11 (28.2)</td><td align="left" rowspan="1" colspan="1">14 (41.2)</td><td align="left" rowspan="1" colspan="1">.24</td></tr><tr><td align="left" rowspan="1" colspan="1">Coronary artery bypass</td><td align="left" rowspan="1" colspan="1">19 (26.0)</td><td align="left" rowspan="1" colspan="1">13 (33.3)</td><td align="left" rowspan="1" colspan="1">6 (17.6)</td><td align="left" rowspan="1" colspan="1">.13</td></tr><tr><td align="left" rowspan="1" colspan="1">Valve repair/replacement</td><td align="left" rowspan="1" colspan="1">12 (16.4)</td><td align="left" rowspan="1" colspan="1">4 (10.3)</td><td align="left" rowspan="1" colspan="1">8 (23.5)</td><td align="left" rowspan="1" colspan="1">.13</td></tr><tr><td align="left" rowspan="1" colspan="1">Biventricular pacemaker</td><td align="left" rowspan="1" colspan="1">11 (15.1)</td><td align="left" rowspan="1" colspan="1">7 (17.9)</td><td align="left" rowspan="1" colspan="1">4 (11.8)</td><td align="left" rowspan="1" colspan="1">.46</td></tr><tr><td align="left" rowspan="1" colspan="1">Implanted cardiac defibrillator</td><td align="left" rowspan="1" colspan="1">19 (26.0)</td><td align="left" rowspan="1" colspan="1">13 (33.3)</td><td align="left" rowspan="1" colspan="1">6 (17.6)</td><td align="left" rowspan="1" colspan="1">.13</td></tr><tr><td align="left" rowspan="1" colspan="1">Stroke/cerebrovascular accident</td><td align="left" rowspan="1" colspan="1">9 (12.3)</td><td align="left" rowspan="1" colspan="1">6 (15.4)</td><td align="left" rowspan="1" colspan="1">3 (8.8)</td><td align="left" rowspan="1" colspan="1">.40</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic obstructive pulmonary disease</td><td align="left" rowspan="1" colspan="1">22 (30.1)</td><td align="left" rowspan="1" colspan="1">11 (28.2)</td><td align="left" rowspan="1" colspan="1">11 (32.4)</td><td align="left" rowspan="1" colspan="1">.70</td></tr><tr><td align="left" rowspan="1" colspan="1">Renal disease</td><td align="left" rowspan="1" colspan="1">26 (35.6)</td><td align="left" rowspan="1" colspan="1">15 (38.5)</td><td align="left" rowspan="1" colspan="1">11 (32.4)</td><td align="left" rowspan="1" colspan="1">.59</td></tr><tr><td align="left" rowspan="1" colspan="1">Diabetes</td><td align="left" rowspan="1" colspan="1">38 (52.1)</td><td align="left" rowspan="1" colspan="1">21 (58.3)</td><td align="left" rowspan="1" colspan="1">17 (45.9)</td><td align="left" rowspan="1" colspan="1">.29</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypertension</td><td align="left" rowspan="1" colspan="1">50 (68.5)</td><td align="left" rowspan="1" colspan="1">27 (75.0)</td><td align="left" rowspan="1" colspan="1">23 (62.2)</td><td align="left" rowspan="1" colspan="1">.24</td></tr><tr><td align="left" rowspan="1" colspan="1">Hypercholesterolemia</td><td align="left" rowspan="1" colspan="1">34 (46.6)</td><td align="left" rowspan="1" colspan="1">15 (41.7)</td><td align="left" rowspan="1" colspan="1">19 (51.4)</td><td align="left" rowspan="1" colspan="1">.41</td></tr><tr><td align="left" rowspan="1" colspan="1">Tobacco Smoking</td><td align="left" rowspan="1" colspan="1">31 (42.5)</td><td align="left" rowspan="1" colspan="1">18 (46.2)</td><td align="left" rowspan="1" colspan="1">13 (38.2)</td><td align="left" rowspan="1" colspan="1">.50</td></tr><tr><td align="left" rowspan="1" colspan="1">Body mass index kg/m<sup>2</sup> &#x0003e;35</td><td align="left" rowspan="1" colspan="1">25 (24.2)</td><td align="left" rowspan="1" colspan="1">11 (28.2)</td><td align="left" rowspan="1" colspan="1">14 (41.2)</td><td align="left" rowspan="1" colspan="1">.24</td></tr><tr><td align="left" rowspan="1" colspan="1">Sleep apnea</td><td align="left" rowspan="1" colspan="1">13 (17.8)</td><td align="left" rowspan="1" colspan="1">5 (12.8)</td><td align="left" rowspan="1" colspan="1">8 (23.5)</td><td align="left" rowspan="1" colspan="1">.23</td></tr><tr><td align="left" rowspan="1" colspan="1">Chronic Pain</td><td align="left" rowspan="1" colspan="1">14 (9.2)</td><td align="left" rowspan="1" colspan="1">4 (10.3)</td><td align="left" rowspan="1" colspan="1">10 (29.4)</td><td align="left" rowspan="1" colspan="1">.04<xref ref-type="table-fn" rid="nt104">*</xref>
</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt103"><label/><p>
<italic>NYHA, New York Heart Association; RCT, randomized controlled trial.</italic>
</p></fn><fn id="nt104"><label>*</label><p>
<italic>p&#x0003c;.05.</italic>
</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3c"><title>Psychosocial Descriptives According to RCT Eligibility</title><p>Comparison of the RCT eligible and ineligible patients with respect to clinical psychiatric factors is shown in <xref ref-type="table" rid="pone-0085928-t003">Table 3</xref>. RCT ineligible patients were more likely to receive anti-depressant treatment including amitriptyline (58.8% vs. 23.1%, p&#x0003c;.01) and reported greater severity of depression (PHQ M&#x0200a;=&#x0200a;16.6&#x000b1;5.0 vs. 12.9&#x000b1;7.2, p&#x0200a;=&#x0200a;.02). RCT ineligible patients were also higher consumers of psychotherapy sessions during the HFSMP (M&#x0200a;=&#x0200a;11.5&#x000b1;4.7 vs. 8.5&#x000b1;4.8, p&#x0200a;=&#x0200a;.01).</p><table-wrap id="pone-0085928-t003" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085928.t003</object-id><label>Table 3</label><caption><title>Comparison of RCT eligible and ineligible patients on clinical psychiatric characteristics.</title></caption><alternatives><graphic id="pone-0085928-t003-3" xlink:href="pone.0085928.t003"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">
<italic><underline>Clinical Psychiatric Factors</underline></italic>
</td><td align="left" rowspan="1" colspan="1">Total N(%) N&#x0200a;=&#x0200a;73</td><td align="left" rowspan="1" colspan="1">RCT Eligible N&#x0200a;=&#x0200a;39</td><td align="left" rowspan="1" colspan="1">RCT Ineligible N&#x0200a;=&#x0200a;34</td><td align="left" rowspan="1" colspan="1">P</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Psychotherapy sessions</td><td align="left" rowspan="1" colspan="1">9.8 (4.8)</td><td align="left" rowspan="1" colspan="1">8.5 (4.8)</td><td align="left" rowspan="1" colspan="1">11.5 (4.7)</td><td align="left" rowspan="1" colspan="1">.01<xref ref-type="table-fn" rid="nt106">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Past suicide attempt</td><td align="left" rowspan="1" colspan="1">13 (17.8)</td><td align="left" rowspan="1" colspan="1">5 (12.8)</td><td align="left" rowspan="1" colspan="1">8 (23.5)</td><td align="left" rowspan="1" colspan="1">.23</td></tr><tr><td align="left" rowspan="1" colspan="1">No past psychiatric care</td><td align="left" rowspan="1" colspan="1">53 (72.6)</td><td align="left" rowspan="1" colspan="1">30 (76.9)</td><td align="left" rowspan="1" colspan="1">23 (67.6)</td><td align="left" rowspan="1" colspan="1">.44</td></tr><tr><td align="left" rowspan="1" colspan="1">Medical records depression</td><td align="left" rowspan="1" colspan="1">15 (20.5)</td><td align="left" rowspan="1" colspan="1">5 (12.8)</td><td align="left" rowspan="1" colspan="1">10 (29.4)</td><td align="left" rowspan="1" colspan="1">.08</td></tr><tr><td align="left" rowspan="1" colspan="1">Medical records missing depression diagnosis<xref ref-type="table-fn" rid="nt107">a</xref>
</td><td align="left" rowspan="1" colspan="1">39 (53.4)</td><td align="left" rowspan="1" colspan="1">18 (46.2)</td><td align="left" rowspan="1" colspan="1">21 (61.8)</td><td align="left" rowspan="1" colspan="1">.18</td></tr><tr><td align="left" rowspan="1" colspan="1">Anti-depressant</td><td align="left" rowspan="1" colspan="1">29 (39.7)</td><td align="left" rowspan="1" colspan="1">9 (23.1)</td><td align="left" rowspan="1" colspan="1">20 (58.8)</td><td align="left" rowspan="1" colspan="1">&#x0003c;.01<xref ref-type="table-fn" rid="nt106">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">PHQ-9 total M(SD)</td><td align="left" rowspan="1" colspan="1">14.7 (6.5)</td><td align="left" rowspan="1" colspan="1">12.9 (7.2)</td><td align="left" rowspan="1" colspan="1">16.6 (5.0)</td><td align="left" rowspan="1" colspan="1">.01<xref ref-type="table-fn" rid="nt106">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Any SCID anxiety disorder</td><td align="left" rowspan="1" colspan="1">52 (71.2)</td><td align="left" rowspan="1" colspan="1">26 (66.7)</td><td align="left" rowspan="1" colspan="1">26 (76.5)</td><td align="left" rowspan="1" colspan="1">.36</td></tr><tr><td align="left" rowspan="1" colspan="1">Medical records missing anxiety diagnosis<xref ref-type="table-fn" rid="nt107">a</xref>
</td><td align="left" rowspan="1" colspan="1">42 (57.5)</td><td align="left" rowspan="1" colspan="1">21 (53.8)</td><td align="left" rowspan="1" colspan="1">21 (61.8)</td><td align="left" rowspan="1" colspan="1">.50</td></tr><tr><td align="left" rowspan="1" colspan="1">Current anxiolytic</td><td align="left" rowspan="1" colspan="1">21 (28.8)</td><td align="left" rowspan="1" colspan="1">8 (20.5)</td><td align="left" rowspan="1" colspan="1">13 (38.2)</td><td align="left" rowspan="1" colspan="1">.10</td></tr><tr><td align="left" rowspan="1" colspan="1">GAD-7 M(SD)</td><td align="left" rowspan="1" colspan="1">12.6 (6.7)</td><td align="left" rowspan="1" colspan="1">12.3 (7.1)</td><td align="left" rowspan="1" colspan="1">13.0 (6.4)</td><td align="left" rowspan="1" colspan="1">.67</td></tr><tr><td align="left" rowspan="1" colspan="1">Panic-Screener</td><td align="left" rowspan="1" colspan="1">28 (38.4)</td><td align="left" rowspan="1" colspan="1">13 (33.3)</td><td align="left" rowspan="1" colspan="1">15 (44.1)</td><td align="left" rowspan="1" colspan="1">.35</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt105"><label/><p>
<italic>GAD, Generalized Anxiety Disorder; PHQ, Patient Health Questionnaire; RCT, randomized controlled trial.</italic>
</p></fn><fn id="nt106"><label>*</label><p>
<italic>p&#x0003c;.05.</italic>
</p></fn><fn id="nt107"><label>a</label><p>
<italic>Medical records depression and medical records anxiety inclusive of diagnoses that conflicts with psychologist SCID assessment. Medical records missing depression or anxiety diagnosis evaluates medical record comorbidity lists and hospital discharge summaries in preceding 6 months prior to assessment with the SCID diagnosis.</italic>
</p></fn></table-wrap-foot></table-wrap></sec><sec id="s3d"><title>Mental Health Prevalence Rates</title><p>The prevalence of depression and anxiety disorders is shown in <xref ref-type="table" rid="pone-0085928-t004">Table 4</xref> and stratified according to RCT eligibility. The most common disorders were major depression (60.3%), GAD (57.5%), panic disorder (52.1%) and social phobia (27.4%). Among the patients with a major depression or dysthymia diagnosis, 8/48 did not meet comorbid anxiety diagnosis. Comparison of patients based on RCT ineligibility showed an association with major depression (76.5% vs. 46.2%, p&#x0003c;.01) and dysthymia (26.5% vs. 7.7%, p&#x0200a;=&#x0200a;.03) and was not significantly associated with anxiety disorders.</p><table-wrap id="pone-0085928-t004" orientation="portrait" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0085928.t004</object-id><label>Table 4</label><caption><title>Prevalence of depression and anxiety disorders in heart failure patients referred for psychiatric care.</title></caption><alternatives><graphic id="pone-0085928-t004-4" xlink:href="pone.0085928.t004"/><table frame="hsides" rules="groups"><colgroup span="1"><col align="left" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/><col align="center" span="1"/></colgroup><thead><tr><td align="left" rowspan="1" colspan="1">SCID Diagnosis</td><td align="left" rowspan="1" colspan="1">Total N(%) N&#x0200a;=&#x0200a;73</td><td align="left" rowspan="1" colspan="1">RCT Eligible N&#x0200a;=&#x0200a;39</td><td align="left" rowspan="1" colspan="1">RCT Ineligible N&#x0200a;=&#x0200a;34</td><td align="left" rowspan="1" colspan="1">P</td></tr></thead><tbody><tr><td align="left" rowspan="1" colspan="1">Major Depression</td><td align="left" rowspan="1" colspan="1">44 (60.3)</td><td align="left" rowspan="1" colspan="1">18 (46.2)</td><td align="left" rowspan="1" colspan="1">26 (76.5)</td><td align="left" rowspan="1" colspan="1">&#x0003c;.01<xref ref-type="table-fn" rid="nt109">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Dysthymia</td><td align="left" rowspan="1" colspan="1">12 (16.4)</td><td align="left" rowspan="1" colspan="1">3 (7.7)</td><td align="left" rowspan="1" colspan="1">9 (26.5)</td><td align="left" rowspan="1" colspan="1">.03<xref ref-type="table-fn" rid="nt109">*</xref>
</td></tr><tr><td align="left" rowspan="1" colspan="1">Panic +- agoraphobia</td><td align="left" rowspan="1" colspan="1">38 (52.1)</td><td align="left" rowspan="1" colspan="1">17 (43.6)</td><td align="left" rowspan="1" colspan="1">21 (61.8)</td><td align="left" rowspan="1" colspan="1">.12</td></tr><tr><td align="left" rowspan="1" colspan="1">Generalized anxiety disorder</td><td align="left" rowspan="1" colspan="1">42 (57.5)</td><td align="left" rowspan="1" colspan="1">19 (48.7)</td><td align="left" rowspan="1" colspan="1">23 (67.6)</td><td align="left" rowspan="1" colspan="1">.10</td></tr><tr><td align="left" rowspan="1" colspan="1">Post-traumatic stress disorder</td><td align="left" rowspan="1" colspan="1">14 (19.2)</td><td align="left" rowspan="1" colspan="1">5 (12.8)</td><td align="left" rowspan="1" colspan="1">9 (26.5)</td><td align="left" rowspan="1" colspan="1">.14</td></tr><tr><td align="left" rowspan="1" colspan="1">Obsessive-compulsive disorder</td><td align="left" rowspan="1" colspan="1">5 (6.8)</td><td align="left" rowspan="1" colspan="1">3 (7.7)</td><td align="left" rowspan="1" colspan="1">2 (5.9)</td><td align="left" rowspan="1" colspan="1">1.0</td></tr><tr><td align="left" rowspan="1" colspan="1">Social phobia</td><td align="left" rowspan="1" colspan="1">20 (27.4)</td><td align="left" rowspan="1" colspan="1">8 (20.5)</td><td align="left" rowspan="1" colspan="1">12 (35.3)</td><td align="left" rowspan="1" colspan="1">.16</td></tr><tr><td align="left" rowspan="1" colspan="1">Adjustment disorder</td><td align="left" rowspan="1" colspan="1">14 (19.2)</td><td align="left" rowspan="1" colspan="1">9 (25.0)</td><td align="left" rowspan="1" colspan="1">5 (13.5)</td><td align="left" rowspan="1" colspan="1">.21</td></tr></tbody></table></alternatives><table-wrap-foot><fn id="nt108"><label/><p>
<italic>RCT, randomized controlled trial; SCID, Structured Clinical Interview.</italic>
</p></fn><fn id="nt109"><label>*</label><p>
<italic>p&#x0003c;.05.</italic>
</p></fn></table-wrap-foot></table-wrap></sec></sec><sec id="s4"><title>Discussion</title><p>This study reports the mental health status subsequent to depression and anxiety screening among HF patients. Psychological assessment suggested that patients commonly presented with emotional disorders other than depression including GAD and panic disorder, consistent with other research <xref rid="pone.0085928-Tully2" ref-type="bibr">[54]</xref>, <xref rid="pone.0085928-Serber1" ref-type="bibr">[63]</xref>&#x02013;<xref rid="pone.0085928-Edmondson1" ref-type="bibr">[67]</xref>. However, psychiatric history would preclude nearly half of these HF patients from participation in contemporary depression RCTs based on six standard exclusion criteria identified from Woltz et al&#x02019;s <xref rid="pone.0085928-Woltz1" ref-type="bibr">[32]</xref> systematic review. RCT ineligibility was highest amongst patients with depression disorders. Also, RCT ineligible patients reported greater severity of depression, chronic pain and were higher consumers of psychotherapy. Together the findings indicate that routine depression screening protocols may underestimate or not align with the real world psychiatric needs in HF. Consequently the extant depression treatment evidence may not even apply to half of cardiovascular patients referred for further psychiatric assessment.</p><p>A number of effective treatments for depression have been reported <xref rid="pone.0085928-Khan1" ref-type="bibr">[68]</xref> though effects on suicidality are less clear <xref rid="pone.0085928-Jakobsen1" ref-type="bibr">[69]</xref>. The results here belie the assumption that depression is the only psychosocial factor for which HF patients require mental health care. These findings thus support the recent examples of routine anxiety screening in general cardiovascular patients <xref rid="pone.0085928-Luttik1" ref-type="bibr">[18]</xref>, <xref rid="pone.0085928-Luukinen1" ref-type="bibr">[64]</xref>, <xref rid="pone.0085928-Hood1" ref-type="bibr">[65]</xref>. Hasnain and colleagues <xref rid="pone.0085928-Hasnain1" ref-type="bibr">[22]</xref> highlighted the absence of clinical guidance for individualized treatment plans when comorbid anxiety is present. The extent to which comorbid anxiety affects depression treatment response is unknown even though 30% of cardiac patients with a positive depression screen in a recent RCT met anxiety disorder criteria <xref rid="pone.0085928-Rollman1" ref-type="bibr">[39]</xref>. Clearly a limitation to mental health service provision and routine screening protocols among cardiovascular patients is the paucity of evidence-based treatments for individual anxiety disorders. Encouragingly, Shemesh et al showed that brief imaginal exposure and cognitive-behavioural therapy for PTSD after a cardiovascular event was associated with no marked increase in blood pressure, pulse and mean arterial pressure <xref rid="pone.0085928-Shemesh2" ref-type="bibr">[70]</xref>. However safety of exposure-based anxiety treatments has not been demonstrated for GAD or panic <xref rid="pone.0085928-Tully1" ref-type="bibr">[53]</xref>. These anxiety disorders were among the most common anxiety disorders prevalent here and elsewhere <xref rid="pone.0085928-Tully2" ref-type="bibr">[54]</xref>, <xref rid="pone.0085928-Serber1" ref-type="bibr">[63]</xref> and may raise cardiovascular risk <xref rid="pone.0085928-Kemp1" ref-type="bibr">[71]</xref>. Nevertheless, psychotropic agents are utilized in early psychiatric intervention for anxiety disorders and also those psychiatric disorders which were RCT exclusions (i.e. alcohol/substance abuse, psychosis and bi-polar depression).</p><p>The current findings should not detract from the importance of prior RCT studies <xref rid="pone.0085928-Woltz1" ref-type="bibr">[32]</xref>&#x02013;<xref rid="pone.0085928-Gary1" ref-type="bibr">[36]</xref> and aspects of methodological rigour other than the six external validity criteria evaluated here. Application of appropriate exclusion criteria are essential to maintain internal validity. Other reasons justifying exclusion based on psychiatric criteria include ethical access to more appropriate treatment and reducing heterogeneity <xref rid="pone.0085928-Zetin1" ref-type="bibr">[72]</xref>. Diagnostic comorbidity also serves as a source of bias in depression treatment efficacy RCTs <xref rid="pone.0085928-Mulder1" ref-type="bibr">[73]</xref>.</p><p>The current findings should thus serve to raise awareness regarding psychiatric illness complexity and comorbidity, particularly as treatment-resistant depression increases cardiovascular risk <xref rid="pone.0085928-Carney1" ref-type="bibr">[74]</xref>, <xref rid="pone.0085928-Jiang3" ref-type="bibr">[75]</xref>. Here, RCT ineligibility was primarily associated with depression disorders. Patients with mood disorder were significantly more likely to have personality disorders and active alcohol/substance abuse or dependency. Recently it was also documented that treatment seeking panic disorder patients also reported high rates of active alcohol/substance abuse and personality disorders <xref rid="pone.0085928-Hoertel1" ref-type="bibr">[76]</xref>. The findings support the necessity of comorbidity assessment by qualified professionals after a positive depression screen <xref rid="pone.0085928-Lichtman1" ref-type="bibr">[12]</xref>. Indeed, the clinical importance of such assessments are bolstered by findings that the functional aspects of HF do not correlate with suicide risk <xref rid="pone.0085928-Lossnitzer1" ref-type="bibr">[77]</xref>, whereas personality disorders, anxiety and depression are more established factors that increase suicide risk <xref rid="pone.0085928-Sareen1" ref-type="bibr">[78]</xref>, <xref rid="pone.0085928-Borges1" ref-type="bibr">[79]</xref>.</p><p>The strength of this study was comprehensive psychological assessment after a routine depression and anxiety screening initiative in ambulatory HF patients thus facilitating mental health care tailored to individual patient needs. This study is presented with several limitations that temper the generalizability of these findings. Firstly, the use of anxiety questionnaires may have elicited more referrals for patients with comorbid anxiety-depression such as GAD and panic disorder <xref rid="pone.0085928-Luukinen1" ref-type="bibr">[64]</xref>, <xref rid="pone.0085928-Hood1" ref-type="bibr">[65]</xref>. The referral of panic disorder in particular may correspond to the tendency to focus on dyspnea symptoms in HF treatment <xref rid="pone.0085928-Dharmarajan1" ref-type="bibr">[80]</xref>. Secondly, ethical constraints precluded an evaluation of HF patients that were not routinely screened and/or not referred. Thus there was no comparison of the prevalence of those constituent variables for RCT eligibility in the general HF population. Reports also suggest approximately 27% of cases are not examined in international routine depression screening protocols <xref rid="pone.0085928-Smolderen1" ref-type="bibr">[19]</xref>. Thirdly, it was not known whether there was a selection bias in referrals given the under-representation of patients with cognitive impairment <xref rid="pone.0085928-Vogels1" ref-type="bibr">[81]</xref>. Fourthly, the sample size, comparable or larger than most intervention arms in recent depression RCTs evaluated by Woltz et al <xref rid="pone.0085928-Woltz1" ref-type="bibr">[32]</xref>, was potentially too small to draw broad conclusions regarding the psychiatric treatments needs and screening suggestions of HF patients generally. Fifthly, the pragmatic aspects of routine screening in HF need to be considered within the regional context by contrast to other cardiology settings and international experiences <xref rid="pone.0085928-Luttik1" ref-type="bibr">[18]</xref>, <xref rid="pone.0085928-Smolderen1" ref-type="bibr">[19]</xref>, <xref rid="pone.0085928-Hasnain1" ref-type="bibr">[22]</xref>, <xref rid="pone.0085928-HerrmannLingen1" ref-type="bibr">[30]</xref>, <xref rid="pone.0085928-Luukinen1" ref-type="bibr">[64]</xref>, <xref rid="pone.0085928-Hood1" ref-type="bibr">[65]</xref>, <xref rid="pone.0085928-Wade1" ref-type="bibr">[82]</xref>. These findings from the current HFSMP may not generalise to other hospitals and it is unknown whether depression screening in conjunction with other management strategies in HF might beneficially impact depression remission rates. Finally, the potential for Type I errors is a limitation and as such will require confirmation in independent cohorts.</p><p>In conclusion, implementation of routine depression screening protocols in cardiology settings may underestimate the severity and complexity of psychiatric needs in HF such as comorbid personality disorders, alcohol/substance use, suicide risk and anxiety disorders. Application of six standard exclusion criteria suggested that the extant RCT evidence may not apply to half of HF patients referred for psychiatric care. Further investigation into external validity of depression RCTs in cardiology settings is recommended to better reflect typical HF patient needs <xref rid="pone.0085928-Masoudi1" ref-type="bibr">[83]</xref>. These findings make the case for a specific focus on external validity of RCTs and depression screening protocols as basis for level A guideline recommendations.</p></sec></body><back><ack><p>The authors thank the heart failure nurses Lyn Chan, Tim Pearson, Renata Surnak, Jeff Briggs, Lin Sun. The authors also thank Bronwyn Pesudovs for her assistance with managing the ethics application and compliance. The authors also thank Andrew Vincent for his statistical advice.</p></ack><ref-list><title>References</title><ref id="pone.0085928-Ferrari1"><label>1</label><mixed-citation publication-type="journal">
<name><surname>Ferrari</surname><given-names>AJ</given-names></name>, <name><surname>Charlson</surname><given-names>FJ</given-names></name>, <name><surname>Norman</surname><given-names>RE</given-names></name>, <name><surname>Patten</surname><given-names>SB</given-names></name>, <name><surname>Freedman</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Burden of Depressive Disorders by Country, Sex, Age, and Year: Findings from the Global Burden of Disease Study 2010</article-title>. <source>PLoS Med</source>
<volume>10</volume>: <fpage>e1001547</fpage>.<pub-id pub-id-type="pmid">24223526</pub-id></mixed-citation></ref><ref id="pone.0085928-Rutledge1"><label>2</label><mixed-citation publication-type="journal">
<name><surname>Rutledge</surname><given-names>T</given-names></name>, <name><surname>Reis</surname><given-names>VA</given-names></name>, <name><surname>Linke</surname><given-names>SE</given-names></name>, <name><surname>Greenberg</surname><given-names>BH</given-names></name>, <name><surname>Mills</surname><given-names>PJ</given-names></name> (<year>2006</year>) <article-title>Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes</article-title>. <source>J Am Coll Cardiol</source>
<volume>48</volume>: <fpage>1527</fpage>&#x02013;<lpage>1537</lpage>.<pub-id pub-id-type="pmid">17045884</pub-id></mixed-citation></ref><ref id="pone.0085928-American1"><label>3</label><mixed-citation publication-type="other">American Psychiatric Association (2000) Diagnostic and statistical manual of mental disorders: DSM-IV-TR. Washington, D.C.: American Psychiatric Association.</mixed-citation></ref><ref id="pone.0085928-Jiang1"><label>4</label><mixed-citation publication-type="journal">
<name><surname>Jiang</surname><given-names>W</given-names></name>, <name><surname>Alexander</surname><given-names>J</given-names></name>, <name><surname>Christopher</surname><given-names>E</given-names></name>, <name><surname>Kuchibhatla</surname><given-names>M</given-names></name>, <name><surname>Gaulden</surname><given-names>LH</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure</article-title>. <source>Arch Intern Med</source>
<volume>161</volume>: <fpage>1849</fpage>&#x02013;<lpage>1856</lpage>.<pub-id pub-id-type="pmid">11493126</pub-id></mixed-citation></ref><ref id="pone.0085928-OConnor1"><label>5</label><mixed-citation publication-type="journal">
<name><surname>O&#x02019;Connor</surname><given-names>CM</given-names></name>, <name><surname>Jiang</surname><given-names>W</given-names></name>, <name><surname>Kuchibhatla</surname><given-names>M</given-names></name>, <name><surname>Mehta</surname><given-names>RH</given-names></name>, <name><surname>Clary</surname><given-names>GL</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Antidepressant use, depression, and survival in patients with heart failure</article-title>. <source>Arch Intern Med</source>
<volume>168</volume>: <fpage>2232</fpage>&#x02013;<lpage>2237</lpage>.<pub-id pub-id-type="pmid">19001200</pub-id></mixed-citation></ref><ref id="pone.0085928-Smith1"><label>6</label><mixed-citation publication-type="journal">
<name><surname>Smith</surname><given-names>DH</given-names></name>, <name><surname>Johnson</surname><given-names>ES</given-names></name>, <name><surname>Blough</surname><given-names>DK</given-names></name>, <name><surname>Thorp</surname><given-names>ML</given-names></name>, <name><surname>Yang</surname><given-names>X</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Predicting costs of care in heart failure patients</article-title>. <source>BMC Health Serv Res</source>
<volume>12</volume>: <fpage>434</fpage>.<pub-id pub-id-type="pmid">23194470</pub-id></mixed-citation></ref><ref id="pone.0085928-Baumeister1"><label>7</label><mixed-citation publication-type="journal">
<name><surname>Baumeister</surname><given-names>H</given-names></name>, <name><surname>Hutter</surname><given-names>N</given-names></name>, <name><surname>Bengel</surname><given-names>J</given-names></name>, <name><surname>H&#x000e4;rter</surname><given-names>M</given-names></name> (<year>2011</year>) <article-title>Quality of life in somatically ill persons with comorbid mental disorders: a systematic review and meta-analysis</article-title>. <source>Psychother Psychosom</source>
<volume>80</volume>: <fpage>275</fpage>&#x02013;<lpage>286</lpage>.<pub-id pub-id-type="pmid">21646822</pub-id></mixed-citation></ref><ref id="pone.0085928-Jaarsma1"><label>8</label><mixed-citation publication-type="journal">
<name><surname>Jaarsma</surname><given-names>T</given-names></name>, <name><surname>Johansson</surname><given-names>PJ</given-names></name>, <name><surname>&#x000c5;gren</surname><given-names>S</given-names></name>, <name><surname>Str&#x000f6;mberg</surname><given-names>A</given-names></name> (<year>2010</year>) <article-title>Quality of life and symptoms of depression in advanced heart failure patients and their partners</article-title>. <source>Curr Opin Supp Pall Care</source>
<volume>4</volume>: <fpage>233</fpage>&#x02013;<lpage>237</lpage>.</mixed-citation></ref><ref id="pone.0085928-Samartzis1"><label>9</label><mixed-citation publication-type="journal">
<name><surname>Samartzis</surname><given-names>L</given-names></name>, <name><surname>Dimopoulos</surname><given-names>S</given-names></name>, <name><surname>Tziongourou</surname><given-names>M</given-names></name>, <name><surname>Nanas</surname><given-names>S</given-names></name> (<year>2013</year>) <article-title>Effect of psychosocial interventions on quality of life in patients with chronic heart failure: A meta-analysis of randomized controlled trials</article-title>. <source>J Card Fail</source>
<volume>19</volume>: <fpage>125</fpage>&#x02013;<lpage>134</lpage>.<pub-id pub-id-type="pmid">23384638</pub-id></mixed-citation></ref><ref id="pone.0085928-Holzapfel1"><label>10</label><mixed-citation publication-type="journal">
<name><surname>Holzapfel</surname><given-names>N</given-names></name>, <name><surname>Lowe</surname><given-names>B</given-names></name>, <name><surname>Wild</surname><given-names>B</given-names></name>, <name><surname>Schellberg</surname><given-names>D</given-names></name>, <name><surname>Zugck</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Self-care and depression in patients with chronic heart failure</article-title>. <source>Heart Lung</source>
<volume>38</volume>: <fpage>392</fpage>&#x02013;<lpage>397</lpage>.<pub-id pub-id-type="pmid">19755189</pub-id></mixed-citation></ref><ref id="pone.0085928-Jaarsma2"><label>11</label><mixed-citation publication-type="journal">
<name><surname>Jaarsma</surname><given-names>T</given-names></name>, <name><surname>Lesman-Leegte</surname><given-names>I</given-names></name>, <name><surname>Hillege</surname><given-names>HL</given-names></name>, <name><surname>Veeger</surname><given-names>NJ</given-names></name>, <name><surname>Sanderman</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Depression and the Usefulness of a Disease Management Program in Heart Failure. Insights From the COACH (Coordinating study evaluating Outcomes of Advising and Counseling in Heart failure) Study</article-title>. <source>J Am Coll Cardiol</source>
<volume>55</volume>: <fpage>1837</fpage>&#x02013;<lpage>1843</lpage>.<pub-id pub-id-type="pmid">20413035</pub-id></mixed-citation></ref><ref id="pone.0085928-Lichtman1"><label>12</label><mixed-citation publication-type="journal">
<name><surname>Lichtman</surname><given-names>JH</given-names></name>, <name><surname>Bigger</surname><given-names>JT</given-names><suffix>Jr</suffix></name>, <name><surname>Blumenthal</surname><given-names>JA</given-names></name>, <name><surname>Frasure-Smith</surname><given-names>N</given-names></name>, <name><surname>Kaufmann</surname><given-names>PG</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association</article-title>. <source>Circ</source>
<volume>118</volume>: <fpage>1768</fpage>&#x02013;<lpage>1775</lpage>.</mixed-citation></ref><ref id="pone.0085928-ChronicHeartFailureGuidelinesExpertWriting1"><label>13</label><mixed-citation publication-type="other">Chronic Heart Failure Guidelines Expert Writing Panel (2011) Guidelines for the prevention, detection and management of chronic heart failure in Australia. National Heart Foundation of Australia and the Cardiac Society of Australia and New Zealand.</mixed-citation></ref><ref id="pone.0085928-OrthGomer1"><label>14</label><mixed-citation publication-type="journal">
<name><surname>Orth-Gomer</surname><given-names>K</given-names></name>, <name><surname>Albus</surname><given-names>C</given-names></name>, <name><surname>Bages</surname><given-names>N</given-names></name>, <name><surname>DeBacker</surname><given-names>G</given-names></name>, <name><surname>Deter</surname><given-names>HC</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Psychosocial considerations in the European guidelines for prevention of cardiovascular diseases in clinical practice: Third Joint Task Force</article-title>. <source>Int J Behav Med</source>
<volume>12</volume>: <fpage>132</fpage>&#x02013;<lpage>141</lpage>.<pub-id pub-id-type="pmid">16083316</pub-id></mixed-citation></ref><ref id="pone.0085928-Albus1"><label>15</label><mixed-citation publication-type="journal">
<name><surname>Albus</surname><given-names>C</given-names></name>, <name><surname>Jordan</surname><given-names>J</given-names></name>, <name><surname>Herrmann-Lingen</surname><given-names>C</given-names></name> (<year>2004</year>) <article-title>Screening for psychosocial risk factors in patients with coronary heart disease-recommendations for clinical practice</article-title>. <source>Eur J Cardiovasc Prev Rehabil</source>
<volume>11</volume>: <fpage>75</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="pmid">15167210</pub-id></mixed-citation></ref><ref id="pone.0085928-McMurray1"><label>16</label><mixed-citation publication-type="journal">
<name><surname>McMurray</surname><given-names>JJV</given-names></name>, <name><surname>Adamopoulos</surname><given-names>S</given-names></name>, <name><surname>Anker</surname><given-names>SD</given-names></name>, <name><surname>Auricchio</surname><given-names>A</given-names></name>, <name><surname>B&#x000f6;hm</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2012</article-title>. <source>Eur J Heart Fail</source>
<volume>14</volume>: <fpage>803</fpage>&#x02013;<lpage>869</lpage>.<pub-id pub-id-type="pmid">22828712</pub-id></mixed-citation></ref><ref id="pone.0085928-Lainscak1"><label>17</label><mixed-citation publication-type="journal">
<name><surname>Lainscak</surname><given-names>M</given-names></name>, <name><surname>Blue</surname><given-names>L</given-names></name>, <name><surname>Clark</surname><given-names>AL</given-names></name>, <name><surname>Dahlstr&#x000f6;m</surname><given-names>U</given-names></name>, <name><surname>Dickstein</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Self-care management of heart failure: practical recommendations from the Patient Care Committee of the Heart Failure Association of the European Society of Cardiology</article-title>. <source>Eur J Heart Fail</source>
<volume>13</volume>: <fpage>115</fpage>&#x02013;<lpage>126</lpage>.<pub-id pub-id-type="pmid">21148593</pub-id></mixed-citation></ref><ref id="pone.0085928-Luttik1"><label>18</label><mixed-citation publication-type="journal">
<name><surname>Luttik</surname><given-names>MLA</given-names></name>, <name><surname>Jaarsma</surname><given-names>T</given-names></name>, <name><surname>Sanderman</surname><given-names>R</given-names></name>, <name><surname>Fleer</surname><given-names>J</given-names></name> (<year>2011</year>) <article-title>The advisory brought to practice. Routine screening on depression (and anxiety) in coronary heart disease; consequences and implications</article-title>. <source>Eur J Cardiovasc Nurs</source>
<volume>10</volume>: <fpage>228</fpage>&#x02013;<lpage>233</lpage>.<pub-id pub-id-type="pmid">20875772</pub-id></mixed-citation></ref><ref id="pone.0085928-Smolderen1"><label>19</label><mixed-citation publication-type="journal">
<name><surname>Smolderen</surname><given-names>KG</given-names></name>, <name><surname>Buchanan</surname><given-names>D</given-names></name>, <name><surname>Amin</surname><given-names>A</given-names></name>, <name><surname>Gosch</surname><given-names>K</given-names></name>, <name><surname>Nugent</surname><given-names>K</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Real-World Lessons From the Implementation of a Depression Screening Protocol in Acute Myocardial Infarction Patients: Implications for the American Heart Association Depression Screening Advisory</article-title>. <source>Circ Cardiovasc Qual Outcomes</source>
<volume>4</volume>: <fpage>283</fpage>&#x02013;<lpage>292</lpage>.<pub-id pub-id-type="pmid">21505152</pub-id></mixed-citation></ref><ref id="pone.0085928-Shemesh1"><label>20</label><mixed-citation publication-type="journal">
<name><surname>Shemesh</surname><given-names>E</given-names></name>, <name><surname>Annunziato</surname><given-names>RA</given-names></name>, <name><surname>Rubinstein</surname><given-names>D</given-names></name>, <name><surname>Sultan</surname><given-names>S</given-names></name>, <name><surname>Malhotra</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Screening for depression and suicidality in patients with cardiovascular illnesses</article-title>. <source>Am J Cardiol</source>
<volume>104</volume>: <fpage>1194</fpage>&#x02013;<lpage>1197</lpage>.<pub-id pub-id-type="pmid">19840561</pub-id></mixed-citation></ref><ref id="pone.0085928-Caro1"><label>21</label><mixed-citation publication-type="journal">
<name><surname>Caro</surname><given-names>MA</given-names></name>, <name><surname>Sowden</surname><given-names>GL</given-names></name>, <name><surname>Mastromauro</surname><given-names>CA</given-names></name>, <name><surname>Mahnks</surname><given-names>S</given-names></name>, <name><surname>Beach</surname><given-names>SR</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Risk factors for positive depression screens in hospitalized cardiac patients</article-title>. <source>J Cardiol</source>
<volume>60</volume>: <fpage>72</fpage>&#x02013;<lpage>77</lpage>.<pub-id pub-id-type="pmid">22436292</pub-id></mixed-citation></ref><ref id="pone.0085928-Hasnain1"><label>22</label><mixed-citation publication-type="journal">
<name><surname>Hasnain</surname><given-names>M</given-names></name>, <name><surname>Vieweg</surname><given-names>WVR</given-names></name>, <name><surname>Lesnefsky</surname><given-names>EJ</given-names></name>, <name><surname>Pandurangi</surname><given-names>AK</given-names></name> (<year>2011</year>) <article-title>Depression screening in patients with coronary heart disease: A critical evaluation of the AHA guidelines</article-title>. <source>J Psychosom Res</source>
<volume>71</volume>: <fpage>6</fpage>&#x02013;<lpage>12</lpage>.<pub-id pub-id-type="pmid">21665006</pub-id></mixed-citation></ref><ref id="pone.0085928-Holzapfel2"><label>23</label><mixed-citation publication-type="journal">
<name><surname>Holzapfel</surname><given-names>N</given-names></name>, <name><surname>Zugck</surname><given-names>C</given-names></name>, <name><surname>M&#x000fc;ller-Tasch</surname><given-names>T</given-names></name>, <name><surname>L&#x000f6;we</surname><given-names>B</given-names></name>, <name><surname>Wild</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>Routine Screening for Depression and Quality of Life in Outpatients With Congestive Heart Failure</article-title>. <source>Psychosomatics</source>
<volume>48</volume>: <fpage>112</fpage>&#x02013;<lpage>116</lpage>.<pub-id pub-id-type="pmid">17329603</pub-id></mixed-citation></ref><ref id="pone.0085928-Yeager1"><label>24</label><mixed-citation publication-type="journal">
<name><surname>Yeager</surname><given-names>KR</given-names></name>, <name><surname>Binkley</surname><given-names>PF</given-names></name>, <name><surname>Saveanu</surname><given-names>RV</given-names></name>, <name><surname>Golden-Kreutz</surname><given-names>DM</given-names></name>, <name><surname>Dembe</surname><given-names>AE</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Screening and Identification of Depression Among Patients with Coronary Heart Disease and Congestive Heart Failure</article-title>. <source>Heart Fail Clin</source>
<volume>7</volume>: <fpage>69</fpage>&#x02013;<lpage>74</lpage>.<pub-id pub-id-type="pmid">21109209</pub-id></mixed-citation></ref><ref id="pone.0085928-Sowden1"><label>25</label><mixed-citation publication-type="journal">
<name><surname>Sowden</surname><given-names>G</given-names></name>, <name><surname>Mastromauro</surname><given-names>CA</given-names></name>, <name><surname>Januzzi</surname><given-names>JL</given-names></name>, <name><surname>Fricchione</surname><given-names>GL</given-names></name>, <name><surname>Huffman</surname><given-names>JC</given-names></name> (<year>2010</year>) <article-title>Detection of depression in cardiac inpatients: feasibility and results of systematic screening</article-title>. <source>Am Heart J</source>
<volume>159</volume>: <fpage>780</fpage>&#x02013;<lpage>787</lpage>.<pub-id pub-id-type="pmid">20435186</pub-id></mixed-citation></ref><ref id="pone.0085928-Burton1"><label>26</label><mixed-citation publication-type="journal">
<name><surname>Burton</surname><given-names>C</given-names></name>, <name><surname>Simpson</surname><given-names>C</given-names></name>, <name><surname>Anderson</surname><given-names>N</given-names></name> (<year>2013</year>) <article-title>Diagnosis and treatment of depression following routine screening in patients with coronary heart disease or diabetes: a database cohort study</article-title>. <source>Psychol Med</source>
<volume>43</volume>: <fpage>529</fpage>&#x02013;<lpage>537</lpage>.<pub-id pub-id-type="pmid">22804849</pub-id></mixed-citation></ref><ref id="pone.0085928-Jani1"><label>27</label><mixed-citation publication-type="journal">
<name><surname>Jani</surname><given-names>BD</given-names></name>, <name><surname>Purves</surname><given-names>D</given-names></name>, <name><surname>Barry</surname><given-names>S</given-names></name>, <name><surname>Cavanagh</surname><given-names>J</given-names></name>, <name><surname>McLean</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Challenges and Implications of Routine Depression Screening for Depression in Chronic Disease and Multimorbidity: A Cross Sectional Study</article-title>. <source>PLoS ONE</source>
<volume>8</volume>: <fpage>e74610</fpage>.<pub-id pub-id-type="pmid">24058602</pub-id></mixed-citation></ref><ref id="pone.0085928-Thombs1"><label>28</label><mixed-citation publication-type="journal">
<name><surname>Thombs</surname><given-names>BD</given-names></name>, <name><surname>de Jonge</surname><given-names>P</given-names></name>, <name><surname>Coyne</surname><given-names>JC</given-names></name>, <name><surname>Whooley</surname><given-names>MA</given-names></name>, <name><surname>Frasure-Smith</surname><given-names>N</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Depression screening and patient outcomes in cardiovascular care: a systematic review</article-title>. <source>J Am Med Assoc</source>
<volume>300</volume>: <fpage>2161</fpage>&#x02013;<lpage>2171</lpage>.</mixed-citation></ref><ref id="pone.0085928-Thombs2"><label>29</label><mixed-citation publication-type="journal">
<name><surname>Thombs</surname><given-names>BD</given-names></name>, <name><surname>Roseman</surname><given-names>M</given-names></name>, <name><surname>Coyne</surname><given-names>JC</given-names></name>, <name><surname>de Jonge</surname><given-names>P</given-names></name>, <name><surname>Delisle</surname><given-names>VC</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Does Evidence Support the American Heart Association&#x02019;s Recommendation to Screen Patients for Depression in Cardiovascular Care? An Updated Systematic Review</article-title>. <source>PLoS ONE</source>
<volume>8</volume>: <fpage>e52654</fpage>.<pub-id pub-id-type="pmid">23308116</pub-id></mixed-citation></ref><ref id="pone.0085928-HerrmannLingen1"><label>30</label><mixed-citation publication-type="journal">
<name><surname>Herrmann-Lingen</surname><given-names>C</given-names></name> (<year>2011</year>) <article-title>Steps towards integrated psychosomatic medicine&#x02013;the example of psychocardiology</article-title>. <source>J Psychosom Res</source>
<volume>70</volume>: <fpage>111</fpage>&#x02013;<lpage>115</lpage>.<pub-id pub-id-type="pmid">21262412</pub-id></mixed-citation></ref><ref id="pone.0085928-Annunziato1"><label>31</label><mixed-citation publication-type="journal">
<name><surname>Annunziato</surname><given-names>RA</given-names></name>, <name><surname>Rubinstein</surname><given-names>D</given-names></name>, <name><surname>Sheikh</surname><given-names>S</given-names></name>, <name><surname>Maurer</surname><given-names>M</given-names></name>, <name><surname>Cotter</surname><given-names>G</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Site matters: winning the hearts and minds of patients in a cardiology clinic</article-title>. <source>Psychosomatics</source>
<volume>49</volume>: <fpage>386</fpage>&#x02013;<lpage>391</lpage>.<pub-id pub-id-type="pmid">18794506</pub-id></mixed-citation></ref><ref id="pone.0085928-Woltz1"><label>32</label><mixed-citation publication-type="journal">
<name><surname>Woltz</surname><given-names>PC</given-names></name>, <name><surname>Chapa</surname><given-names>DW</given-names></name>, <name><surname>Friedmann</surname><given-names>E</given-names></name>, <name><surname>Son</surname><given-names>H</given-names></name>, <name><surname>Akintade</surname><given-names>B</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Effects of interventions on depression in heart failure: a systematic review</article-title>. <source>Heart Lung</source>
<volume>41</volume>: <fpage>469</fpage>&#x02013;<lpage>483</lpage>.<pub-id pub-id-type="pmid">22938627</pub-id></mixed-citation></ref><ref id="pone.0085928-Jiang2"><label>33</label><mixed-citation publication-type="journal">
<name><surname>Jiang</surname><given-names>W</given-names></name>, <name><surname>O&#x02019;Connor</surname><given-names>C</given-names></name>, <name><surname>Silva</surname><given-names>SG</given-names></name>, <name><surname>Kuchibhatla</surname><given-names>M</given-names></name>, <name><surname>Cuffe</surname><given-names>MS</given-names></name>, <etal>et al</etal> (<year>2008</year>) <article-title>Safety and efficacy of sertraline for depression in patients with CHF (SADHART-CHF): a randomized, double-blind, placebo-controlled trial of sertraline for major depression with congestive heart failure</article-title>. <source>Am Heart J</source>
<volume>156</volume>: <fpage>437</fpage>&#x02013;<lpage>444</lpage>.<pub-id pub-id-type="pmid">18760123</pub-id></mixed-citation></ref><ref id="pone.0085928-Cully1"><label>34</label><mixed-citation publication-type="journal">
<name><surname>Cully</surname><given-names>JA</given-names></name>, <name><surname>Stanley</surname><given-names>MA</given-names></name>, <name><surname>Deswal</surname><given-names>A</given-names></name>, <name><surname>Hanania</surname><given-names>NA</given-names></name>, <name><surname>Phillips</surname><given-names>LL</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Cognitive-behavioral therapy for chronic cardiopulmonary conditions: preliminary outcomes from an open trial</article-title>. <source>Prim Care Companion J Clin Psychiatry</source>
<volume>12</volume>: <fpage>PCC.09m00896</fpage>.<pub-id pub-id-type="pmid">21085552</pub-id></mixed-citation></ref><ref id="pone.0085928-OHea1"><label>35</label><mixed-citation publication-type="journal">
<name><surname>O&#x02019;Hea</surname><given-names>E</given-names></name>, <name><surname>Houseman</surname><given-names>J</given-names></name>, <name><surname>Bedek</surname><given-names>K</given-names></name>, <name><surname>Sposato</surname><given-names>R</given-names></name> (<year>2009</year>) <article-title>The use of cognitive behavioral therapy in the treatment of depression for individuals with CHF</article-title>. <source>Heart Fail Rev</source>
<volume>14</volume>: <fpage>13</fpage>&#x02013;<lpage>20</lpage>.<pub-id pub-id-type="pmid">18228140</pub-id></mixed-citation></ref><ref id="pone.0085928-Gary1"><label>36</label><mixed-citation publication-type="journal">
<name><surname>Gary</surname><given-names>RA</given-names></name>, <name><surname>Dunbar</surname><given-names>SB</given-names></name>, <name><surname>Higgins</surname><given-names>MK</given-names></name>, <name><surname>Musselman</surname><given-names>DL</given-names></name>, <name><surname>Smith</surname><given-names>AL</given-names></name> (<year>2010</year>) <article-title>Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure</article-title>. <source>J Psychosom Res</source>
<volume>69</volume>: <fpage>119</fpage>&#x02013;<lpage>131</lpage>.<pub-id pub-id-type="pmid">20624510</pub-id></mixed-citation></ref><ref id="pone.0085928-Rothwell1"><label>37</label><mixed-citation publication-type="journal">
<name><surname>Rothwell</surname><given-names>PM</given-names></name> (<year>2005</year>) <article-title>External validity of randomised controlled trials: ?To whom do the results of this trial apply?</article-title>
<source>Lancet</source>
<volume>365</volume>: <fpage>82</fpage>&#x02013;<lpage>93</lpage>.<pub-id pub-id-type="pmid">15639683</pub-id></mixed-citation></ref><ref id="pone.0085928-vanderLem1"><label>38</label><mixed-citation publication-type="journal">
<name><surname>van der Lem</surname><given-names>R</given-names></name>, <name><surname>van der Wee</surname><given-names>NJ</given-names></name>, <name><surname>van Veen</surname><given-names>T</given-names></name>, <name><surname>Zitman</surname><given-names>FG</given-names></name> (<year>2012</year>) <article-title>Efficacy versus effectiveness: a direct comparison of the outcome of treatment for mild to moderate depression in randomized controlled trials and daily practice</article-title>. <source>Psychother Psychosom</source>
<volume>81</volume>: <fpage>226</fpage>&#x02013;<lpage>234</lpage>.<pub-id pub-id-type="pmid">22584117</pub-id></mixed-citation></ref><ref id="pone.0085928-Rollman1"><label>39</label><mixed-citation publication-type="journal">
<name><surname>Rollman</surname><given-names>BL</given-names></name>, <name><surname>Belnap</surname><given-names>BH</given-names></name>, <name><surname>LeMenager</surname><given-names>MS</given-names></name>, <name><surname>Mazumdar</surname><given-names>S</given-names></name>, <name><surname>Houck</surname><given-names>PR</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Telephone-delivered collaborative care for treating post-CABG depression: a randomized controlled trial</article-title>. <source>JAMA</source>
<volume>302</volume>: <fpage>2095</fpage>&#x02013;<lpage>2103</lpage>.<pub-id pub-id-type="pmid">19918088</pub-id></mixed-citation></ref><ref id="pone.0085928-Ruscio1"><label>40</label><mixed-citation publication-type="journal">
<name><surname>Ruscio</surname><given-names>AM</given-names></name>, <name><surname>Holohan</surname><given-names>DR</given-names></name> (<year>2006</year>) <article-title>Applying empirically supported treatments to complex cases: Ethical, empirical, and practical considerations</article-title>. <source>Clin Psychol: Science Pract</source>
<volume>13</volume>: <fpage>146</fpage>&#x02013;<lpage>162</lpage>.</mixed-citation></ref><ref id="pone.0085928-Collins1"><label>41</label><mixed-citation publication-type="journal">
<name><surname>Collins</surname><given-names>PY</given-names></name>, <name><surname>Insel</surname><given-names>TR</given-names></name>, <name><surname>Chockalingam</surname><given-names>A</given-names></name>, <name><surname>Daar</surname><given-names>A</given-names></name>, <name><surname>Maddox</surname><given-names>YT</given-names></name> (<year>2013</year>) <article-title>Grand Challenges in Global Mental Health: Integration in Research, Policy, and Practice</article-title>. <source>PLoS Med</source>
<volume>10</volume>: <fpage>e1001434</fpage>.<pub-id pub-id-type="pmid">23637578</pub-id></mixed-citation></ref><ref id="pone.0085928-Spitzer1"><label>42</label><mixed-citation publication-type="journal">
<name><surname>Spitzer</surname><given-names>RL</given-names></name>, <name><surname>Kroenke</surname><given-names>K</given-names></name>, <name><surname>Williams</surname><given-names>JB</given-names></name> (<year>1999</year>) <article-title>Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire</article-title>. <source>JAMA</source>
<volume>282</volume>: <fpage>1737</fpage>&#x02013;<lpage>1744</lpage>.<pub-id pub-id-type="pmid">10568646</pub-id></mixed-citation></ref><ref id="pone.0085928-McManus1"><label>43</label><mixed-citation publication-type="journal">
<name><surname>McManus</surname><given-names>D</given-names></name>, <name><surname>Pipkin</surname><given-names>SS</given-names></name>, <name><surname>Whooley</surname><given-names>MA</given-names></name> (<year>2005</year>) <article-title>Screening for depression in patients with coronary heart disease (data from the Heart and Soul Study)</article-title>. <source>Am J Cardiol</source>
<volume>96</volume>: <fpage>1076</fpage>&#x02013;<lpage>1081</lpage>.<pub-id pub-id-type="pmid">16214441</pub-id></mixed-citation></ref><ref id="pone.0085928-Kroenke1"><label>44</label><mixed-citation publication-type="journal">
<name><surname>Kroenke</surname><given-names>K</given-names></name>, <name><surname>Spitzer</surname><given-names>RL</given-names></name>, <name><surname>Williams</surname><given-names>JB</given-names></name> (<year>2001</year>) <article-title>The PHQ-9: validity of a brief depression severity measure</article-title>. <source>J Gen Intern Med</source>
<volume>16</volume>: <fpage>606</fpage>&#x02013;<lpage>613</lpage>.<pub-id pub-id-type="pmid">11556941</pub-id></mixed-citation></ref><ref id="pone.0085928-Spitzer2"><label>45</label><mixed-citation publication-type="journal">
<name><surname>Spitzer</surname><given-names>RL</given-names></name>, <name><surname>Kroenke</surname><given-names>K</given-names></name>, <name><surname>Williams</surname><given-names>JB</given-names></name>, <name><surname>Lowe</surname><given-names>B</given-names></name> (<year>2006</year>) <article-title>A brief measure for assessing generalized anxiety disorder: the GAD-7</article-title>. <source>Arch Intern Med</source>
<volume>166</volume>: <fpage>1092</fpage>&#x02013;<lpage>1097</lpage>.<pub-id pub-id-type="pmid">16717171</pub-id></mixed-citation></ref><ref id="pone.0085928-Kroenke2"><label>46</label><mixed-citation publication-type="journal">
<name><surname>Kroenke</surname><given-names>K</given-names></name>, <name><surname>Spitzer</surname><given-names>RL</given-names></name>, <name><surname>Williams</surname><given-names>JB</given-names></name>, <name><surname>Lowe</surname><given-names>B</given-names></name> (<year>2010</year>) <article-title>The Patient Health Questionnaire Somatic, Anxiety, and Depressive Symptom Scales: a systematic review</article-title>. <source>Gen Hosp Psych</source>
<volume>32</volume>: <fpage>345</fpage>&#x02013;<lpage>359</lpage>.</mixed-citation></ref><ref id="pone.0085928-Lwe1"><label>47</label><mixed-citation publication-type="journal">
<name><surname>L&#x000f6;we</surname><given-names>B</given-names></name>, <name><surname>Gr&#x000e4;fe</surname><given-names>K</given-names></name>, <name><surname>Zipfel</surname><given-names>S</given-names></name>, <name><surname>Spitzer</surname><given-names>RL</given-names></name>, <name><surname>Herrmann-Lingen</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Detecting panic disorder in medical and psychosomatic outpatients: Comparative validation of the Hospital Anxiety and Depression Scale, the Patient Health Questionnaire, a screening question, and physicians&#x02019; diagnosis</article-title>. <source>J Psychosom Res</source>
<volume>55</volume>: <fpage>515</fpage>&#x02013;<lpage>519</lpage>.<pub-id pub-id-type="pmid">14642981</pub-id></mixed-citation></ref><ref id="pone.0085928-Pedersen1"><label>48</label><mixed-citation publication-type="journal">
<name><surname>Pedersen</surname><given-names>SS</given-names></name> (<year>2001</year>) <article-title>Post-traumatic stress disorder in patients with coronary artery disease: a review and evaluation of the risk</article-title>. <source>Scand J Psychol</source>
<volume>42</volume>: <fpage>445</fpage>&#x02013;<lpage>451</lpage>.<pub-id pub-id-type="pmid">11771814</pub-id></mixed-citation></ref><ref id="pone.0085928-Doerfler1"><label>49</label><mixed-citation publication-type="journal">
<name><surname>Doerfler</surname><given-names>LA</given-names></name>, <name><surname>Paraskos</surname><given-names>JA</given-names></name> (<year>2005</year>) <article-title>Post-traumatic stress disorder in patients with coronary artery disease: screening and management implications</article-title>. <source>Can J Cardiol</source>
<volume>21</volume>: <fpage>689</fpage>&#x02013;<lpage>697</lpage>.<pub-id pub-id-type="pmid">16003452</pub-id></mixed-citation></ref><ref id="pone.0085928-Haworth1"><label>50</label><mixed-citation publication-type="journal">
<name><surname>Haworth</surname><given-names>JE</given-names></name>, <name><surname>Moniz-Cook</surname><given-names>E</given-names></name>, <name><surname>Clark</surname><given-names>AL</given-names></name>, <name><surname>Wang</surname><given-names>M</given-names></name>, <name><surname>Waddington</surname><given-names>R</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Prevalence and predictors of anxiety and depression in a sample of chronic heart failure patients with left ventricular systolic dysfunction</article-title>. <source>Eur J Heart Fail</source>
<volume>7</volume>: <fpage>803</fpage>&#x02013;<lpage>808</lpage>.<pub-id pub-id-type="pmid">16054436</pub-id></mixed-citation></ref><ref id="pone.0085928-Ballenger1"><label>51</label><mixed-citation publication-type="journal">
<name><surname>Ballenger</surname><given-names>JC</given-names></name>, <name><surname>Davidson</surname><given-names>JR</given-names></name>, <name><surname>Lecrubier</surname><given-names>Y</given-names></name>, <name><surname>Nutt</surname><given-names>DJ</given-names></name>, <name><surname>Roose</surname><given-names>SP</given-names></name>, <etal>et al</etal> (<year>2001</year>) <article-title>Consensus statement on depression, anxiety, and cardiovascular disease</article-title>. <source>J Clin Psych</source>
<volume>62</volume>: <fpage>24</fpage>&#x02013;<lpage>27</lpage>.</mixed-citation></ref><ref id="pone.0085928-Scherrer1"><label>52</label><mixed-citation publication-type="journal">
<name><surname>Scherrer</surname><given-names>JF</given-names></name>, <name><surname>Chrusciel</surname><given-names>T</given-names></name>, <name><surname>Zeringue</surname><given-names>A</given-names></name>, <name><surname>Garfield</surname><given-names>LD</given-names></name>, <name><surname>Hauptman</surname><given-names>PJ</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Anxiety disorders increase risk for incident myocardial infarction in depressed and nondepressed Veterans Administration patients</article-title>. <source>Am Heart J</source>
<volume>159</volume>: <fpage>772</fpage>&#x02013;<lpage>779</lpage>.<pub-id pub-id-type="pmid">20435185</pub-id></mixed-citation></ref><ref id="pone.0085928-Tully1"><label>53</label><mixed-citation publication-type="journal">
<name><surname>Tully</surname><given-names>PJ</given-names></name>, <name><surname>Cosh</surname><given-names>SM</given-names></name>, <name><surname>Baune</surname><given-names>BT</given-names></name> (<year>2013</year>) <article-title>A review of the affects of worry and generalized anxiety disorder upon cardiovascular health and coronary heart disease</article-title>. <source>Psychol Health Med</source>
<volume>18</volume>: <fpage>627</fpage>&#x02013;<lpage>644</lpage>.<pub-id pub-id-type="pmid">23324073</pub-id></mixed-citation></ref><ref id="pone.0085928-Tully2"><label>54</label><mixed-citation publication-type="journal">
<name><surname>Tully</surname><given-names>PJ</given-names></name>, <name><surname>Cosh</surname><given-names>SM</given-names></name> (<year>2013</year>) <article-title>Generalized anxiety disorder prevalence and comorbidity with depression in coronary heart disease: a meta analysis</article-title>. <source>J Health Psychol</source>
<volume>18</volume>: <fpage>1601</fpage>&#x02013;<lpage>1616</lpage>.<pub-id pub-id-type="pmid">23300050</pub-id></mixed-citation></ref><ref id="pone.0085928-First1"><label>55</label><mixed-citation publication-type="other">First MB, Gibbon M, Spitzer RL, Williams JBW, Benjamin LS (1997) Structured Clinical Interview for DSM-IV Axis II Personality Disorders, (SCID-II). Washington, D.C.: American Psychiatric Press, Inc.</mixed-citation></ref><ref id="pone.0085928-First2"><label>56</label><mixed-citation publication-type="other">First MB, Williams JBW, Spitzer RL, Gibbon M (2007) Structured Clinical Interview for DSM-IV-TR Axis I Disorders, Clinical Trials Version (SCID-I/P W/psychotic screen). New York: Biometrics Research.</mixed-citation></ref><ref id="pone.0085928-Gottlieb1"><label>57</label><mixed-citation publication-type="journal">
<name><surname>Gottlieb</surname><given-names>SS</given-names></name>, <name><surname>Kop</surname><given-names>WJ</given-names></name>, <name><surname>Thomas</surname><given-names>SA</given-names></name>, <name><surname>Katzen</surname><given-names>S</given-names></name>, <name><surname>Vesely</surname><given-names>MR</given-names></name>, <etal>et al</etal> (<year>2007</year>) <article-title>A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure</article-title>. <source>Am Heart J</source>
<volume>153</volume>: <fpage>868</fpage>&#x02013;<lpage>873</lpage>.<pub-id pub-id-type="pmid">17452166</pub-id></mixed-citation></ref><ref id="pone.0085928-Lekakis1"><label>58</label><mixed-citation publication-type="journal">
<name><surname>Lekakis</surname><given-names>J</given-names></name>, <name><surname>Ikonomidis</surname><given-names>I</given-names></name>, <name><surname>Papoutsi</surname><given-names>Z</given-names></name>, <name><surname>Moutsatsou</surname><given-names>P</given-names></name>, <name><surname>Nikolaou</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Selective serotonin re-uptake inhibitors decrease the cytokine-induced endothelial adhesion molecule expression, the endothelial adhesiveness to monocytes and the circulating levels of vascular adhesion molecules</article-title>. <source>Int J Cardiol</source>
<volume>139</volume>: <fpage>150</fpage>&#x02013;<lpage>158</lpage>.<pub-id pub-id-type="pmid">19004511</pub-id></mixed-citation></ref><ref id="pone.0085928-Fraguas1"><label>59</label><mixed-citation publication-type="journal">
<name><surname>Fraguas</surname><given-names>R</given-names></name>, <name><surname>da Silva Telles</surname><given-names>RM</given-names></name>, <name><surname>Alves</surname><given-names>TC</given-names></name>, <name><surname>Andrei</surname><given-names>AM</given-names></name>, <name><surname>Rays</surname><given-names>J</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>A double-blind, placebo-controlled treatment trial of citalopram for major depressive disorder in older patients with heart failure: the relevance of the placebo effect and psychological symptoms</article-title>. <source>Contemp Clin Trials</source>
<volume>30</volume>: <fpage>205</fpage>&#x02013;<lpage>211</lpage>.<pub-id pub-id-type="pmid">19470312</pub-id></mixed-citation></ref><ref id="pone.0085928-Sullivan1"><label>60</label><mixed-citation publication-type="journal">
<name><surname>Sullivan</surname><given-names>MJ</given-names></name>, <name><surname>Wood</surname><given-names>L</given-names></name>, <name><surname>Terry</surname><given-names>J</given-names></name>, <name><surname>Brantley</surname><given-names>J</given-names></name>, <name><surname>Charles</surname><given-names>A</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>The Support, Education, and Research in Chronic Heart Failure Study (SEARCH): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure</article-title>. <source>Am Heart J</source>
<volume>157</volume>: <fpage>84</fpage>&#x02013;<lpage>90</lpage>.<pub-id pub-id-type="pmid">19081401</pub-id></mixed-citation></ref><ref id="pone.0085928-Yu1"><label>61</label><mixed-citation publication-type="journal">
<name><surname>Yu</surname><given-names>DS</given-names></name>, <name><surname>Lee</surname><given-names>DT</given-names></name>, <name><surname>Woo</surname><given-names>J</given-names></name>, <name><surname>Hui</surname><given-names>E</given-names></name> (<year>2007</year>) <article-title>Non-pharmacological interventions in older people with heart failure: effects of exercise training and relaxation therapy</article-title>. <source>Gerontol</source>
<volume>53</volume>: <fpage>74</fpage>&#x02013;<lpage>81</lpage>.</mixed-citation></ref><ref id="pone.0085928-Rothman1"><label>62</label><mixed-citation publication-type="journal">
<name><surname>Rothman</surname><given-names>KJ</given-names></name> (<year>1990</year>) <article-title>No adjustments are needed for multiple comparisons</article-title>. <source>Epidemiol</source>
<volume>1</volume>: <fpage>43</fpage>&#x02013;<lpage>46</lpage>.</mixed-citation></ref><ref id="pone.0085928-Serber1"><label>63</label><mixed-citation publication-type="other">Serber ER, Todaro JF, Tilkemeier PL, Niaura R (2009) Prevalence and characteristics of multiple psychiatric disorders in cardiac rehabilitation patients. J Cardiopulm Rehabil Prev 29: 161&#x02013;168; quiz 169&#x02013;170.</mixed-citation></ref><ref id="pone.0085928-Luukinen1"><label>64</label><mixed-citation publication-type="journal">
<name><surname>Luukinen</surname><given-names>H</given-names></name>, <name><surname>Jokelainen</surname><given-names>J</given-names></name>, <name><surname>Hedberg</surname><given-names>P</given-names></name> (<year>2010</year>) <article-title>The relationships between high-sensitivity C-reactive protein and incident depressed mood among older adults</article-title>. <source>Scand J Clin Lab Invest</source>
<volume>70</volume>: <fpage>75</fpage>&#x02013;<lpage>79</lpage>.<pub-id pub-id-type="pmid">20170291</pub-id></mixed-citation></ref><ref id="pone.0085928-Hood1"><label>65</label><mixed-citation publication-type="journal">
<name><surname>Hood</surname><given-names>KK</given-names></name>, <name><surname>Lawrence</surname><given-names>JM</given-names></name>, <name><surname>Anderson</surname><given-names>A</given-names></name>, <name><surname>Bell</surname><given-names>R</given-names></name>, <name><surname>Dabelea</surname><given-names>D</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Metabolic and inflammatory links to depression in youth with diabetes</article-title>. <source>Diabetes Care</source>
<volume>35</volume>: <fpage>2443</fpage>&#x02013;<lpage>2446</lpage>.<pub-id pub-id-type="pmid">23033243</pub-id></mixed-citation></ref><ref id="pone.0085928-Tully3"><label>66</label><mixed-citation publication-type="other">Tully PJ, Baune BT (in press) Comorbid anxiety disorders alter the association between cardiovascular diseases and depression: the German National Health Interview and Examination Survey. Soc Psych Psych Epidemiol.</mixed-citation></ref><ref id="pone.0085928-Edmondson1"><label>67</label><mixed-citation publication-type="journal">
<name><surname>Edmondson</surname><given-names>D</given-names></name>, <name><surname>Richardson</surname><given-names>S</given-names></name>, <name><surname>Falzon</surname><given-names>L</given-names></name>, <name><surname>Davidson</surname><given-names>KW</given-names></name>, <name><surname>Mills</surname><given-names>MA</given-names></name>, <etal>et al</etal> (<year>2012</year>) <article-title>Posttraumatic Stress Disorder Prevalence and Risk of Recurrence in Acute Coronary Syndrome Patients: A Meta-analytic Review</article-title>. <source>PLoS ONE</source>
<volume>7</volume>: <fpage>e38915</fpage>.<pub-id pub-id-type="pmid">22745687</pub-id></mixed-citation></ref><ref id="pone.0085928-Khan1"><label>68</label><mixed-citation publication-type="journal">
<name><surname>Khan</surname><given-names>A</given-names></name>, <name><surname>Faucett</surname><given-names>J</given-names></name>, <name><surname>Lichtenberg</surname><given-names>P</given-names></name>, <name><surname>Kirsch</surname><given-names>I</given-names></name>, <name><surname>Brown</surname><given-names>WA</given-names></name> (<year>2012</year>) <article-title>A Systematic Review of Comparative Efficacy of Treatments and Controls for Depression</article-title>. <source>PLoS ONE</source>
<volume>7</volume>: <fpage>e41778</fpage>.<pub-id pub-id-type="pmid">22860015</pub-id></mixed-citation></ref><ref id="pone.0085928-Jakobsen1"><label>69</label><mixed-citation publication-type="journal">
<name><surname>Jakobsen</surname><given-names>JC</given-names></name>, <name><surname>Hansen</surname><given-names>JL</given-names></name>, <name><surname>Storeb&#x000f8;</surname><given-names>OJ</given-names></name>, <name><surname>Simonsen</surname><given-names>E</given-names></name>, <name><surname>Gluud</surname><given-names>C</given-names></name> (<year>2011</year>) <article-title>The Effects of Cognitive Therapy versus &#x02018;No Intervention&#x02019; for Major Depressive Disorder</article-title>. <source>PLoS ONE</source>
<volume>6</volume>: <fpage>e28299</fpage>.<pub-id pub-id-type="pmid">22174786</pub-id></mixed-citation></ref><ref id="pone.0085928-Shemesh2"><label>70</label><mixed-citation publication-type="journal">
<name><surname>Shemesh</surname><given-names>E</given-names></name>, <name><surname>Annunziato</surname><given-names>RA</given-names></name>, <name><surname>Weatherley</surname><given-names>BD</given-names></name>, <name><surname>Cotter</surname><given-names>G</given-names></name>, <name><surname>Feaganes</surname><given-names>JR</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>A randomized controlled trial of the safety and promise of cognitive-behavioral therapy using imaginal exposure in patients with posttraumatic stress disorder resulting from cardiovascular illness</article-title>. <source>J Clin Psychiatry</source>
<volume>72</volume>: <fpage>168</fpage>&#x02013;<lpage>174</lpage>.<pub-id pub-id-type="pmid">20441725</pub-id></mixed-citation></ref><ref id="pone.0085928-Kemp1"><label>71</label><mixed-citation publication-type="journal">
<name><surname>Kemp</surname><given-names>AH</given-names></name>, <name><surname>Quintana</surname><given-names>DS</given-names></name>, <name><surname>Felmingham</surname><given-names>KL</given-names></name>, <name><surname>Matthews</surname><given-names>S</given-names></name>, <name><surname>Jelinek</surname><given-names>HF</given-names></name> (<year>2012</year>) <article-title>Depression, comorbid anxiety disorders, and heart rate variability in physically healthy, unmedicated patients: Implications for cardiovascular risk</article-title>. <source>PLoS One</source>
<volume>7</volume>: <fpage>e30777</fpage>.<pub-id pub-id-type="pmid">22355326</pub-id></mixed-citation></ref><ref id="pone.0085928-Zetin1"><label>72</label><mixed-citation publication-type="journal">
<name><surname>Zetin</surname><given-names>M</given-names></name>, <name><surname>Hoepner</surname><given-names>CT</given-names></name> (<year>2007</year>) <article-title>Relevance of exclusion criteria in antidepressant clinical trials: a replication study</article-title>. <source>J Clin Psychopharmacol</source>
<volume>27</volume>: <fpage>295</fpage>&#x02013;<lpage>301</lpage>.<pub-id pub-id-type="pmid">17502778</pub-id></mixed-citation></ref><ref id="pone.0085928-Mulder1"><label>73</label><mixed-citation publication-type="journal">
<name><surname>Mulder</surname><given-names>RT</given-names></name>, <name><surname>Frampton</surname><given-names>C</given-names></name>, <name><surname>Joyce</surname><given-names>PR</given-names></name>, <name><surname>Porter</surname><given-names>R</given-names></name> (<year>2003</year>) <article-title>Randomized controlled trials in psychiatry. Part II: Their relationship to clinical practice</article-title>. <source>Aus NZ J Psych</source>
<volume>37</volume>: <fpage>265</fpage>&#x02013;<lpage>269</lpage>.</mixed-citation></ref><ref id="pone.0085928-Carney1"><label>74</label><mixed-citation publication-type="journal">
<name><surname>Carney</surname><given-names>RM</given-names></name>, <name><surname>Freedland</surname><given-names>KE</given-names></name> (<year>2009</year>) <article-title>Treatment-resistant depression and mortality after acute coronary syndrome</article-title>. <source>Am J Psych</source>
<volume>166</volume>: <fpage>410</fpage>&#x02013;<lpage>417</lpage>.</mixed-citation></ref><ref id="pone.0085928-Jiang3"><label>75</label><mixed-citation publication-type="journal">
<name><surname>Jiang</surname><given-names>W</given-names></name>, <name><surname>Krishnan</surname><given-names>R</given-names></name>, <name><surname>Kuchibhatla</surname><given-names>M</given-names></name>, <name><surname>Cuffe</surname><given-names>MS</given-names></name>, <name><surname>Martsberger</surname><given-names>C</given-names></name>, <etal>et al</etal> (<year>2011</year>) <article-title>Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF Study)</article-title>. <source>Am J Cardiol</source>
<volume>107</volume>: <fpage>545</fpage>&#x02013;<lpage>551</lpage>.<pub-id pub-id-type="pmid">21295172</pub-id></mixed-citation></ref><ref id="pone.0085928-Hoertel1"><label>76</label><mixed-citation publication-type="journal">
<name><surname>Hoertel</surname><given-names>N</given-names></name>, <name><surname>Le Strat</surname><given-names>Y</given-names></name>, <name><surname>De Maricourt</surname><given-names>P</given-names></name>, <name><surname>Limosin</surname><given-names>F</given-names></name>, <name><surname>Dubertret</surname><given-names>C</given-names></name> (<year>2013</year>) <article-title>Are subjects in treatment trials of panic disorder representative of patients in routine clinical practice? Results from a national sample</article-title>. <source>J Affect Disord</source>
<volume>146</volume>: <fpage>383</fpage>&#x02013;<lpage>389</lpage>.<pub-id pub-id-type="pmid">23084184</pub-id></mixed-citation></ref><ref id="pone.0085928-Lossnitzer1"><label>77</label><mixed-citation publication-type="journal">
<name><surname>Lossnitzer</surname><given-names>N</given-names></name>, <name><surname>Muller-Tasch</surname><given-names>T</given-names></name>, <name><surname>Lowe</surname><given-names>B</given-names></name>, <name><surname>Zugck</surname><given-names>C</given-names></name>, <name><surname>Nelles</surname><given-names>M</given-names></name>, <etal>et al</etal> (<year>2009</year>) <article-title>Exploring potential associations of suicidal ideation and ideas of self-harm in patients with congestive heart failure</article-title>. <source>Depress Anxiety</source>
<volume>26</volume>: <fpage>764</fpage>&#x02013;<lpage>768</lpage>.<pub-id pub-id-type="pmid">19658120</pub-id></mixed-citation></ref><ref id="pone.0085928-Sareen1"><label>78</label><mixed-citation publication-type="journal">
<name><surname>Sareen</surname><given-names>J</given-names></name>, <name><surname>Cox</surname><given-names>BJ</given-names></name>, <name><surname>Afifi</surname><given-names>TO</given-names></name>, <name><surname>de Graaf</surname><given-names>R</given-names></name>, <name><surname>Asmundson</surname><given-names>GJ</given-names></name>, <etal>et al</etal> (<year>2005</year>) <article-title>Anxiety disorders and risk for suicidal ideation and suicide attempts: a population-based longitudinal study of adults</article-title>. <source>Arch Gen Psychiatry</source>
<volume>62</volume>: <fpage>1249</fpage>&#x02013;<lpage>1257</lpage>.<pub-id pub-id-type="pmid">16275812</pub-id></mixed-citation></ref><ref id="pone.0085928-Borges1"><label>79</label><mixed-citation publication-type="journal">
<name><surname>Borges</surname><given-names>G</given-names></name>, <name><surname>Nock</surname><given-names>MK</given-names></name>, <name><surname>Haro Abad</surname><given-names>JM</given-names></name>, <name><surname>Hwang</surname><given-names>I</given-names></name>, <name><surname>Sampson</surname><given-names>NA</given-names></name>, <etal>et al</etal> (<year>2010</year>) <article-title>Twelve-month prevalence of and risk factors for suicide attempts in the World Health Organization World Mental Health Surveys</article-title>. <source>J Clin Psychiatry</source>
<volume>71</volume>: <fpage>1617</fpage>&#x02013;<lpage>1628</lpage>.<pub-id pub-id-type="pmid">20816034</pub-id></mixed-citation></ref><ref id="pone.0085928-Dharmarajan1"><label>80</label><mixed-citation publication-type="journal">
<name><surname>Dharmarajan</surname><given-names>K</given-names></name>, <name><surname>Strait</surname><given-names>KM</given-names></name>, <name><surname>Lagu</surname><given-names>T</given-names></name>, <name><surname>Lindenauer</surname><given-names>PK</given-names></name>, <name><surname>Tinetti</surname><given-names>ME</given-names></name>, <etal>et al</etal> (<year>2013</year>) <article-title>Acute Decompensated Heart Failure Is Routinely Treated as a Cardiopulmonary Syndrome</article-title>. <source>PLoS ONE</source>
<volume>8</volume>: <fpage>e78222</fpage>.<pub-id pub-id-type="pmid">24250751</pub-id></mixed-citation></ref><ref id="pone.0085928-Vogels1"><label>81</label><mixed-citation publication-type="journal">
<name><surname>Vogels</surname><given-names>RL</given-names></name>, <name><surname>Scheltens</surname><given-names>P</given-names></name>, <name><surname>Schroeder-Tanka</surname><given-names>JM</given-names></name>, <name><surname>Weinstein</surname><given-names>HC</given-names></name> (<year>2007</year>) <article-title>Cognitive impairment in heart failure: a systematic review of the literature</article-title>. <source>Eur J Heart Fail</source>
<volume>9</volume>: <fpage>440</fpage>&#x02013;<lpage>449</lpage>.<pub-id pub-id-type="pmid">17174152</pub-id></mixed-citation></ref><ref id="pone.0085928-Wade1"><label>82</label><mixed-citation publication-type="journal">
<name><surname>Wade</surname><given-names>V</given-names></name>, <name><surname>Cheok</surname><given-names>F</given-names></name>, <name><surname>Schrader</surname><given-names>G</given-names></name>, <name><surname>Hordacre</surname><given-names>AL</given-names></name>, <name><surname>Marker</surname><given-names>J</given-names></name> (<year>2005</year>) <article-title>Depression after cardiac hospitalisation&#x02013;the Identifying Depression as a Comorbid Condition (IDACC) study</article-title>. <source>Aus Fam Phys</source>
<volume>34</volume>: <fpage>985</fpage>&#x02013;<lpage>989</lpage>.</mixed-citation></ref><ref id="pone.0085928-Masoudi1"><label>83</label><mixed-citation publication-type="journal">
<name><surname>Masoudi</surname><given-names>FA</given-names></name>, <name><surname>Havranek</surname><given-names>EP</given-names></name>, <name><surname>Wolfe</surname><given-names>P</given-names></name>, <name><surname>Gross</surname><given-names>CP</given-names></name>, <name><surname>Rathore</surname><given-names>SS</given-names></name>, <etal>et al</etal> (<year>2003</year>) <article-title>Most hospitalized older persons do not meet the enrollment criteria for clinical trials in heart failure</article-title>. <source>Am Heart J</source>
<volume>146</volume>: <fpage>250</fpage>&#x02013;<lpage>257</lpage>.<pub-id pub-id-type="pmid">12891192</pub-id></mixed-citation></ref></ref-list></back></article>